Publikationen


2021 Impact Factor
   
1. Lindemann M, Wilde B, Friebus-Kardash J, Gäckler A, Witzke O, Dittmer U, Horn PA, Kribben A, Mülling N, Eisenberger U. Comparison of Humoral and Cellular CMV Immunity in Patients Awaiting Kidney Transplantation. Diagnostics. 2021 Sep 16; 11(9): 1688. doi.org/10.3390/diagnostics11091688. 3.7
   
2. Thümmler L, Schwarzkopf S, Knop D, Ross JA, Berg V, Horn PA, Lindemann M. Comparison of SARS-CoV-2- and HCoV-specific T cell response using IFN-γ ELISpot. Diagnostics. 2021 Aug 10; 11 (8): 1439. doi: 10.3390/diagnostics11081439. 3.7
   
3. Steindor M, Stehling F, Olivier M, Kehrmann J, Diricks M, Maurer FP, Horn PA, Straßburg S, Welsner M, Sutharsan S, Lindemann M. Species-specific interferon-gamma release assay for the diagnosis of Mycobacterium abscessus complex infection. Front Microbiol. 2021 Jul 12. doi: 10.3389/fmicb.2021.692395. 5.6
   
4. Budeus B, Kibler A, Brauser M, Homp E, Bronischewski K, Ross JA, Görgens A, Weniger MA, Dunst J, Kreslavsky T, Vitoriano da Conceição Castro S, Murke F, Oakes CC, Rusch P, Andrikos D, Kern P, Köninger A, Lindemann M, Johansson P, Hansen W, Lundell AC, Rudin A, Dürig J, Giebel B, Hoffmann D, Küppers R, Seifert M. Human cord blood B cells differ from the adult counterpart by conserved Ig repertoires and accelerated response dynamics. J Immunol. 2021 Jun 11; ji2100113. doi: 10.4049/jimmunol.2100113. [online ahead of print] 5.4
   
5. Subburayalu J, Dolff S, Xu S, Sun M, Lindemann M, Heinold A, Heinemann FM, Cohen Tervaert JW, Eisenberger U, Korth J, Brinkhoff A, Kribben A, Witzke O, Wilde B. Characterization of follicular T helper cells and donor-specific T helper cells in renal transplant patients with de novo donor-specific HLA-antibodies. Clin Immunol. 2021 May; 226: 108698. doi: 10.1016/j.clim.2021.108698. [online ahead of print] 4.0
   
6. Lindemann M, Krawczyk A, Dolff S, Konik M, Rohn H, Platte M, Thuemmler L, Schwarzkopf S, Schipper L, Bormann M, van de Sand L, Breyer M, Klump H, Knop D, Lenz V, Temme C, Dittmer U, Horn PA, Witzke O. SARS-CoV-2-specific humoral and cellular immunity in two renal transplant and two haemodialysis patients treated with convalescent plasma. J Med Virol. 2021 May; 93(5): 3047-3054. doi: 10.1002/jmv.26840. 2.3
   
7. Lindemann M, Lenz V, Knop D, Klump H, Alt M, Aufderhorst UW, Schipper L, Schwarzkopf S, Meller L, Steckel N, Koldehoff M, Heinold A, Heinemann FM, Fischer J, Hutschenreuter G, Knabbe C, Dolff S, Brenner T, Dittmer U, Witzke O, Herbstreit F, Horn PA, Krawczyk A. Convalescent plasma treatment of critically ill intensive care COVID-19 patients. Transfusion. 2021 May; 61(5): 1394-1403. doi: 10.1111/trf.16392. 3.2
   
8. Cavallaro S, Pevere F, Stridfeldt F, Görgens A, Paba C, Sahu SS, Mamand DR, Gupta D, El Andaloussi S, Linnros J, Dev A. Multiparametric Profiling of Single Nanoscale Extracellular Vesicles by Combined Atomic Force and Fluorescence Microscopy: Correlation and Heterogeneity in Their Molecular and Biophysical Features. Small. 2021 Apr; 17(14): e2008155. doi: 10.1002/smll.202008155. 13.3
   
9. Kibler A, Budeus B, Homp E, Bronischewski K, Berg V, Sellmann L, Murke F, Heinold A, Heinemann FM, Lindemann M, Bekeredjian-Ding I, Horn PA, Kirschning CJ, Küppers R, Seifert M. Systematic memory B cell archiving and random display shape the human splenic marginal zone throughout life. J Exp Med. 2021 Apr 5; 218(4): e20201952. doi: 10.1084/jem.20201952. 14.3
   
10. Reusing SB, Manser AR, Groeneveld-Krentz S, Rebmann V, Horn PA, Meisel R, Karawajew L, Borkhardt A, Uhrberg M, Babor F. HLA-E expression constitutes a novel determinant for ALL disease monitoring following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2021 Jul; 56(7): 1723-1727. doi: 10.1038/s41409-021-01231-y. 5.5
   
11. Váraljai R, Elouali S, Lueong SS, Wistuba-Hamprecht K, Seremet T, Siveke JT, Becker JC, Sucker A, Paschen A, Horn PA, Neyns B, Weide B, Schadendorf D, Roesch A. The predictive and prognostic significance of cell-free DNA concentration in melanoma. J Eur Acad Dermatol Venereol. 2021 Feb; 35(2): 387-395. doi: 10.1111/jdv.16766. 6.2
   
12. Meurer T, Crivello P, Metzing MF, Kester M, Megger DA, Chen W, van Veelen PA, van Balen P, Westendorf A, Homa G, Layer SE, Turki AT, Griffioen M, Horn PA, Sitek B, Beelen DW, Falkenburg JHF, Arrieta-Bolaños E, Fleischhauer K. Permissive HLA-DPB1 mismatches in HCT depend on immunopeptidome divergence and editing by HLA-DM. Blood. 2021 Feb 18; 137(7): 923-928. doi: 10.1182/blood.2020008464. 22.1
   
13. Wagner-Drouet E, Teschner D, Wolschke, C, Schäfer-Eckart K, Gärtner J, Mielke S, Schreder M, Kobbe G, Hilgendorf I, Klein S, Verbeek M, Ditschkowski, M, Koch M, Lindemann M, Schmidt T, Rascle A, Barabas S, Deml L, Wagner R, Wolff D. Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation. Diagnostics. 2021 Feb 15; 11(2): 312. 3.7
   
14. Wagner-Drouet E, Teschner D, Wolschke C, Janson D, Schäfer-Eckart K Gärtner J, Mielke S, Schreder M, Kobbe G, Kondakci M, Hilgendorf I, von Lilienfeld-Toal M, Klein S, Heidenreich D, Kreil S, Verbeek M, Graß S, Ditschkowski M, Gromke T, Koch M, Hünig T, Lindemann M, Schmidt T, Rascle A, Guldan H, Barabas S, Deml L, Wagner R, Wolff D. Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent CMV reactivation after HSCT. Haematologica. 2021 Feb 1; 106(2): 363-374. doi: 10.3324/haematol.2019.229252. 9.9
   
15. Gliga S, Fiedler M, Dornieden T, Achterfeld A, Paul A, Horn PA, Herzer K, Lindemann M. Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients. Vaccines (Basel). 2021 Jan; 9(2): 88. doi: https://doi.org/10.3390/. 4.4
   
16. Schwarzkopf S, Krawczyk A, Knop D, Klump H, Heinold A, Heinemann FM, Thümmler L, Temme C, Breyer M, Witzke O, Dittmer U, Lenz V, Horn PA, Lindemann M. Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG. Emerg Infect Dis. 2021 Jan; 27(1): 122-129. doi: 10.3201/2701.203772. 6.9
   
17. Hoerster K, Uhrberg M, Wiek C, Horn PA, Hanenberg H, Heinrichs S. HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for "Off-the-Shelf" Immunotherapy. Front Immunol. 2021 Jan 29; 11: 586168. doi: 10.3389/fimmu.2020.586168. 7.6
   
18. Ohlsson S, Kathemann S, Pilic D, Prusinskas B, Baba HA, Theurer S, Dechene A, Paul A, Heinold A, Hoyer PF, Lainka E. Protocol liver biopsies in stable long-term pediatric liver transplant recipients: risk or benefit? Eur J Gastroenterol Hepatol. 2021 Jan 6. doi: 10.1097/MEG.0000000000002006. [Epub ahead of print] 2.6
2020 Impact Factor
   
1. Börger V, Staubach S, Dittrich R, Stambouli O, Giebel B. Scaled Isolation of Mesenchymal Stem/Stromal Cell‐Derived Extracellular Vesicles. Current Protocols in Stem Cell Biology. 2020 Dec; 55(1): e128. doi: 10.1002/cpsc.128. 1.0
   
2. Silini AR, Di Pietro R, Lang-Olip I, Alviano F, Banerjee A, Basile M, Borutinskaite V, Eissner G, Gellhaus A, Giebel B, Huang YC, Janev A, Kreft ME, Kupper N, Abadía-Molina AC, Olivares EG, Pandolfi A, Papait A, Pozzobon M, Ruiz-Ruiz C, Soritau O, Susman S, Szukiewicz D, Weidinger A, Wolbank S, Huppertz B, Parolini O. Perinatal Derivatives: Where Do We Stand? A Roadmap of the Human Placenta and Consensus for Tissue and Cell Nomenclature. Front Bioeng Biotechnol. 2020 Dec 17; 8: 610544. doi: 10.3389/fbioe.2020.610544. 3.6
   
3. Kaminski N, Köster C, Mouloud Y, Börger V, Felderhoff-Müser U, Bendix I, Giebel B, Herz J. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Reduce Neuroinflammation, Promote Neural Cell Proliferation and Improve Oligodendrocyte Maturation in Neonatal Hypoxic-Ischemic Brain Injury. Front Cell Neurosci. 2020 Dec 10; 14: 601176. doi: 10.3389/fncel.2020.601176. 3.9
   
4. Weiss DJ, Lim SK, Rohde E, Witwer KW, Giebel B. Weiss Response to Sengupta et al. Stem Cells Dev. 2020 Dec;29(24): 1533-1534. doi: 10.1089/scd.2020.0114. 3.2
   
5. Lueong SS, Herbst A, Liffers ST, Bielefeld N, Horn PA, Tannapfel A, Reinacher-Schick A, Hinke A, Hegewisch-Becker S, Kolligs FT, Siveke JT. Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial. Clin Chem. 2020 Dec 1; 66(12): 1510-1520. doi: 10.1093/clinchem/hvaa223. 7.3
   
6. Huetter FK, Moehlendick B, Knop D, Siffert W. Lack of association of common polymorphisms linked to empathic behavior with self-reported trait empathy in healthy volunteers. Horm Behav. 2020 Nov; 126: 104841. doi: 10.1016/j.yhbeh.2020.104841. 3.7
   
7. Wagner B, Dührsen U, Hüttmann A, Nückel H, Michita RT, Rohn H, Schramm S, Horn PA, Rebmann V. Genetic Variants of the NKG2C/HLA-E Receptor-Ligand Axis Are Determinants of Progression – Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma. Cancers (Basel). 2020 Nov 18; 12(11): 3429. doi: 10.3390/cancers12113429. 6.1
   
8. Chen Y, Hoffmeister LM, Zaun Y, Arnold L, Schmid KW, Giebel B, Klein-Hitpass L, Hanenberg H, Squire A, Reinhardt HC, Dührsen U, Bertram S, Hanoun M. Acute myeloid leukemia-induced remodeling of the human bone marrow niche predicts clinical outcome. Blood Adv. 2020 Oct 27;4(20): 5257-5268. doi: 10.1182/bloodadvances.2020001808. 4.9
   
9. Porto L, You SJ, Attarbaschi A, Cario G, Döring M, Moser O, Mücke U, Poyer F, Temme C, Voigt S, Groll AH, Lauten M, Hattingen E, Lehrnbecher T. Invasive Mold Infection of the Central Nervous System in Immunocompromised Children. J Fungi (Basel). 2020 Oct 16;6(4):226. doi: 10.3390/jof6040226. 4.6
   
10. Hack T, Bertram S, Blair H, Börger V, Büsche G, Denson L, Fruth E, Giebel B, Heidenreich O, Klein-Hitpass L, Kollipara L, Sendker S, Sickmann A, Walter C, von Neuhoff N, Hanenberg H, Reinhardt D, Schneider M, Rasche M. Exposure of Patient-Derived Mesenchymal Stromal Cells to TGFB1 Supports Fibrosis Induction in a Pediatric Acute Megakaryoblastic Leukemia Model. Mol Cancer Res. 2020 Oct; 18(10): 1603-1612. doi: 10.1158/1541-7786. 4.6
   
11. Börger V, Weiss DJ, Anderson JD, Borràs FE, Bussolati B, Carter DRF, Dominici M, Falcón-Pérez JM, Mario Gimona, Hill AF, Hoffman AM, de Kleijn D, Levine BL, Lim R, Lötvall J, Mitsialis SA, Monguió-Tortajada M, Muraca M, Nieuwland R, Nowocin A, O'Driscoll L, Ortiz LA, Phinney DG, Reischl I, Rohde E, Sanzenbacher R, Théry C, Toh WS, Witwer KW, Lim SK, Giebel B. International Society for Extracellular Vesicles ans International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19. Cytotherapy. 2020 Sep; 22(9): 482-485. doi: 10.1016/j.jcyt.2020.05.002. 4.2
   
12. Morandi F, Marimpietri D, Görgens A, Gallo A, Srinivasan RC, El-Andaloussi S, Gramignoli R.Human Amnion Epithelial Cells Impair T Cell Proliferation: The Role of HLA-G and HLA-E Molecules. Cells. 2020 Sep 19; 9(9): 2123. doi: 10.3390/cells9092123. 4.4
   
13. Steens J, Unger K, Klar L, Neureiter A, Wieber K, Hess J, Jakob HG, Klump H, Klein D. Direct conversion of human fibroblasts into therapeutically active vascular wall-typical mesenchymal stem cells. Cell Mol Life Sci. 2020 Sep; 77(17): 3401-3422. doi: 10.1007/s00018-019-03358-0. 6.5
   
14. Conzelmann C, Groß R, Zou M, Krüger F, Görgens A, Gustafsson MO, El Andaloussi S, Münch J, Müller JA. Salivary extracellular vesicles inhibit Zika virus but not SARS-CoV-2 infection. J Extracell Vesicles. 2020 Aug 24; 9(1):1808281. doi: 10.1080/20013078.2020.1808281. 15.0
   
15. Gupta D, Liang X, Pavlova S, Wiklander OPB, Corso G, Zhao Y, Saher O, Bost J, Zickler AM, Piffko A, Maire CL, Ricklefs FL, Gustafsson O, Llorente VC, Gustafsson MO, Bostancioglu RB, Mamand DR, Hagey DW, Görgens A, Nordin JZ, El Andaloussi S. Quantification of extracellular vesicles in vitro and in vivo using sensitive bioluminescence imaging. J Extracell Vesicles. 2020 Aug. 9(1): 1800222, doi: 10.1080/20013078.2020.1800222. 15.0
   
16. Willuweit K, Frey A, Bieniek L, Heinold A, Büchter M, Horn PA, Wedemeyer H, Herzer K. HLA class II donor specific antibodies are associated with graft cirrhosis after liver transplant independent of the mean fluorescence intensity level. BMC Gastroenterol. 2020 Aug 27; 20(1): 288. doi: 10.1186/s12876-020-01427-4. 2.4
   
17. Schwich E, Hò GT, LeMaoult J, Bade-Döding C, Carosella ED, Horn PA, Rebmann V. Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary. Front Immunol. 2020 Aug 21; 11: 2046. doi: 10.3389/fimmu.2020.02046. 5.1
   
18. Viol L, Hata S, Pastor-Peidro A, Neuner A, Murke F, Wuchter P, Ho AD, Giebel B, Pereira G. Nek2 kinase displaces distal appendages from the mother centriole prior to mitosis. J Cell Biol. 2020 Mar 2. 219(3): e201907136. 8.8
   
19. Metzenmacher M, Váraljai R, Hegedüs B, Cima I, Forster J, Schramm A, Scheffler B, Horn PA, Klein CA, Szarvas T, Reis H, Bielefeld N, Roesch A, Aigner C, Kunzmann V, Wiesweg M, Siveke JT, Schuler M, Lueong SS. Plasma next generation sequencing and droplet Digital-qPCR-Based quantification of circulating cell-free RNA for noninvasive early detection of cancer. Cancer (Basel). 2020; 12(2): 353. doi: 10.3390/cancers1202035. 6.2
   
20. Korth J, Wilde B, Dolff S, Anastasiou OE, Krawczyk A, Jahn M, Cordes S, Ross B, Esser S, Lindemann M, Kribben A, Dittmer U, Witzke O, Herrmann A. SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients. J Clin Virol. 2020 Juli; 12: 104437. doi: 10.1016/j.jcv.2020.104437. 3.0
   
21. Lim SK, Giebel B, Weiss DJ, Witwer KW, Rohde E. Re: “Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19” by Sengupta et al. Stem Cells and Development. 2020 Jul; 29(14): 877-878. doi: 10.1089/scd.2020.0089. 3.1
   
22. Sokolova V, Nzou G, van der Meer SB, Ruks T, Heggen M, Loza K, Hagemann N, Murke F, Giebel B, Hermann DM, Atala AJ, Epple M. Ultrasmall gold nanoparticles (2 nm) can penetrate and enter cell nuclei in an in vitro 3D brain spheroid model Acta Biomater. 2020 Jul 15; 111: 349-362. 6.6
   
23. Severmann AC, Jochmann K, Feller K, Bachvarova V, Piombo V, Stange R, Holzer T, Brachvogel B, Esko J, Pap T, Hoffmann D, Vortkamp A. An altered heparan sulfate structure in the articular cartilage protects against osteoarthritis. Osteoarthritis Cartilage. 2020 Jul; 28(7):977-987. doi: 10.1016/j.joca.2020.04.002. 4.8
   
24. Wang C, Börger V, Sardari M, Murke F, Skuljec J, Pul R, Hagemann N, Dzyubenko E, Dittrich R, Gregorius J, Hasenberg M, Kleinschnitz C, Popa-Wagner A, Doeppner TR, Gunzer M, Giebel B, Hermann DM. Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Induce Ischemic Neuroprotection by Modulating Leukocytes and Specifically Neutrophils. Stroke. 2020 Jun; 51(6): 1825-1834. 6.0
   
25. Tertel T, Bremer M, Maire C, Lamszus K, Peine S, Jawad R, Andaloussi SEL, Giebel B, Ricklefs FL, Görgens A. High-Resolution Imaging Flow Cytometry Reveals Impact of Incubation Temperature on Labeling of Extracellular Vesicles With Antibodies. Cytometry A. 2020 Jun; 97(6): 602-609. 3.4
   
26. Grutza R, Moskorz W, Senff T, Bäcker E, Lindemann M, Zimmermann A, Uhrberg M, Lang PA, Timm J, Cosmovici C. NKG2Cpos NK Cells Regulate the Expansion of Cytomegalovirus-Specific CD8 T Cells. J Immunol. 2020 Jun 1; 204(11): 2919-2917. pii: ji1901281. doi: 10.4049/jimmunol.1901281. 4.7
   
27. Bojkova D, Westhaus S, Costa R, Timmer L, Funkenberg N, Korencak M, Streeck H, Vondran F, Broering R, Heinrichs S, Lang KS, Ciesek S. Sofosbuvir Activates EGFR-Dependent Pathways in Hepatoma Cells with Implications for Liver-Related Pathological Processes. Cells. 2020 Apr 17; 9(4): 1003. doi: 10.3390/cells9041003. 5.6
   
28. Oesterreich S, Lindemann M, Goldblatt D, Horn PA, Wilde B, Witzke O. Humoral Response to a 13-valent Pneumococcal Conjugate Vaccine in Kidney Transplant Recipients. Vaccine. 2020 Apr 9; 38(17): 3339-3350. 3.2
   
29. Ben Yahia H, Boujelbene N, Babay W, Ben Safta I, Dhouioui S, Zemni I, Ali Ayadi M, Charfi L, Ouzari HI, Rebmann V, Rizzo R, Mrad K, Driss M, Zidi I. Expression analysis of immune-regulatory molecules HLA-G, HLA-E and IDO in endometrial cancer. Hum Immunol. 2020 Jun; 81(6): 305-313. doi: 10.1016/j.humimm.2020.03.008. 2.2
   
30. Görgens A, Nolan JP. Aiming to Compare Apples to Apples: Analysis of Extracellular Vesicles and Other Nanosized Particles by Flow Cytometry. Cytometry A. 2020 Jun; 97(6): 566 - 568. doi: 10.1002/cyto.a.24173. 3.1
   
31. Sadeghi L, Arvidsson G, Merrien M, M Wasik A, Görgens A, Smith CIE, Sander B, Wright AP. Differential B-Cell Receptor Signaling Requirement for Adhesion of Mantle Cell Lymphoma Cells to Stromal Cells. Cancers (Basel). 2020 May 2; 12(5): 1143. doi: 10.3390/cancers12051143. 6.1
   
32. Mouloud Y, Giebel B, Horn PA, Hanenberg H, Bauer FN. Immortalization strategies for human mesenchymal stromal cells for large scale production of extracellular vesicles. Cytotherapy. May 2020; 22(5): S53-S53.  
   
33. Rohn H, Schwich E, Michita RT, Schramm S, Dolff S, Gaeckler A, Kroth J, Heinemann FM, Wilde B, Trilling M, Horn PA, Kribben A, Witzke O, Rebmann V. HLA-G 3’ untranslated region gene variants are promising prognostic factors for BK polyomavirus replication and acute rejection after living-donor kidney transplant. Human Immunol. 2020 Apr; 81(4): 141-146. doi: 10.1016/j.humimm.2019.09.011. 2.2
   
34. Alashkar F, Herbstreit F, Carpinteiro A, Baum J, Tzalaras A, Aramaya-Singlemann C, Vance C, Lenz V, Gulbins E, Reinhardt D, Beelen DW, Dührsen U, Röth A, Koldehoff M, Liebregts T. Veno-Venous Extracorporeal Membrane Oxygenation in Adult Patients With Sickle Cell Disease and Acute Chest Syndrome: A Single-Center Experience. Hemoglobin. 2020 Mar; 44(2): 71-77. 0.5
   
35. Kontopoulou E, Strachan S, Reinhardt K, Kunz F, Walter C, Walkenfort B, Jastrow H, Hasenberg M, Giebel B, von Neuhoff N, Reinhardt D, Thakur BK. Evaluation of dsDNA from extracellular vesicles (EVs) in pediatric AML diagnostics. Ann Hematol. 2020 Mar; 99(3): 459-475. 2.8
   
36. Ali S, Toews K, Schwiebert S, Klaus A, Winkler A, Grunewald L, Oevermann L, Deubzer HE, Tüns A, Jensen MC, Henssen AG, Eggert A, Schulte JH, Schwich E, Rebmann V, Schramm A, Künkele A. Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4+ CAR T Cell Efficacy. Front Immunol. 2020 Mar 31; 11: 531. doi: 10.3389/fimmu.2020.00531. 4.7
   
37. Abel F, Murke F, Gaida M, Garnier N, Ochsenfarth C, Theiss C, Thielmann M, Kleinbongard P, Giebel B, Peters J, Frey UH. Extracellular Vesicles Isolated From Patients Undergoing Remote Ischemic Preconditioning Decrease Hypoxia-Evoked Apoptosis of Cardiomyoblasts After Isoflurane but Not Propofol Exposure. PLoS One. 2020 Feb 14; 15(2): e0228948. 2.8
   
38. Dampmann M, Görgens A, Möllmann M, Murke F, Dührsen U, Giebel B, Dürig J.CpG stimulation of chronic lymphocytic leukemia cells induces a polarized cell shape and promotes migration in vitro and in vivo. PLoS One. 2020 Feb 10;15(2): e0228674. doi: 10.1371/journal.pone.0228674. eCollection 2020. 2.7
   
39. Welsh JA, Van Der Pol E, Arkesteijn GJA, Bremer M, Brisson A, Coumans F, Dignat-George F, Duggan E, Ghiran I, Giebel B, Görgens A, Hendrix A, Lacroix R, Lannigan J, Libregts S, Lozano-Andrés E, Morales-Kastresana A, Robert S, De Rond L, Tertel T, Tigges J, De Wever O, Yan X, Nieuwland R, Wauben M, Nolan JP, Jones JC. MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments. Journal of Extracellular Vesicles. 2020 Feb 3; 9(1): 1713526. 11.0
   
40. Kordelas L, Schwich E, Lindemann M, Heinemann FM, Buttkereit U, Horn PA, Beelen DW, Rebmann V. Decreased soluble human leukocyte antigen E Levels in patients after allogeneic hematopoietic stem cell transplantation are associated with severe acute and extended chronic graft-versus-host disease and inferior overall survival. Front Immunol. 2020 Jan 10; 10: 3027. doi: 10.3389/fimmu.2019.03027. eCollection 2019. 4.7
   
41. Kordelas L, Görgens A, Radtke S, Horn PA, Beelen DW, Giebel B. Allogeneic transplantation of peripheral blood stem cell grafts results in a massive decrease of primitive hematopoietic progenitor frequencies in reconstituted bone marrows. Bone Marrow Transplant. 2020 Jan; 55(1): 100-109. 4.6
   
42. Ugurel S, Schadendorf D, Horny K, Sucker A, Schramm S, Utikal J, Pföhler C, Herbst R, Schilling B, Blank C, Becker JC, Paschen A, Zimmer L, Livingstone E, Horn PA, Rebmann V. Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma. Ann Oncol. 2020 Jan; 31(1): 144-152. 14.1
   
43. Steens J, Klump H, Klein D. In Vitro Generation of Vascular Wall-Typical Mesenchymal Stem Cells (VW-MSC) from Murine Induced Pluripotent Stem Cells Through VW-MSC-Specific Gene Transfer. Methods Mol Biol. 2020; 2155: 83-97. doi: 10.1007/978-1-0716-0655-1_7.  
   
44. Tertel T, Görgens A, Giebel B. Analysis of individual extracellular vesicles by imaging flow cytometry. Methods Enzymol. 2020; 645: 55-78. doi: 10.1016/bs.mie.2020.05.013.  
   
45. Madel RJ, Börger V, Dittrich R, Bremer M, Baba HA, Brandau S, Buer J, Horn PA, Kirschning C, Giebel B. Large-scale preparations of small extracellular vesicles from conditioned media of mesenchymal stromal cells modulate therapeutic impacts on a newly established Graft-versus-Host-Disease model in batch dependent manners. Cytotherapy. 2020; 22(5): S47-S48.  
   
46. Madel RJ, Börger V, Dittrich R, Bremer B, Tertel T, Ngo Thi Phuong N, Babo HA, Kordelas L, Buer J, Horn PA, Westendorf AM, Brandau S, Kirschning CJ, Giebel B.Independent human mesenchymal stromal cell-derived extracellular vesicle preparations differentially affect symptoms in an advanced murine Graft-versus-Host-Disease model. bioRxiv. 2020; doi: doi.org/2020.12.21.423658.  
   
Staubach S, Gagnon P, Vrabec K, Lojpur T, Peljhan S, Giebel B, Štrancar A. Challenges in Industrial Process Development of Exosome-Based Therapies: Characterizing and Managing Diversity. BioProcess International; 2020. [eBook]  
   
Görgens A, Giebel B. Extracellular vesicles. Essential Current Concepts in Stem Cell Biology, 2020, 219-229. [Buchbeitrag]  
   
Klump H. Hematopoietic stem cells. Essential Current Concepts in Stem Cell Biology, 2020, 1-19. [Buchbeitrag]  
   
2019 Impact Factor
   
1. Malewicz NM, Walstein K, Heine T, Engler A, Bick A, Cox L, Dötsch A, Westendorf AM, Horn PA, Lindemann M, Peters J, Schäfer ST. Early suppression of peripheral mononuclear blood cells in sepsis in response to stimulation with cytomegalovirus, OKT3, and pokeweed mitogen. J Appl Physiol (1985). 2019 Dec 1; 127(6): 1539-1547. 3.1
   
2. Babor F, Peters C, Manser AR, Glogova E, Sauer M, Pötschger U, Ahlmann M, Cario G, Feuchtinger T, Gruhn B, Güngör T, Horn PA, Kremens B, Lang P, Mezger M, Müller I, Mytilineos J, Oevermann L, Pichler H, Scherenschlich N, Schuster FR, Siepermann M, Stachel D, Strahm B, Wössmann W, Escherich G, Zimmermann M, Schrappe M, Borkhardt A, Eckert C, Bader P, Uhrberg M, Meisel R. Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALL. Bone Marrow Transplant. 2019 Nov; 54(11): 1847-1858. 4.6
   
3. Bessa V, Sun M, Meier M, Ye Z, Xu S, Dolff S, Sommerwerck U, Korth J, Taube C, Aigner C, Kamler M, Kribben A, Lindemann M, Witzke O, Wilde B. Expression pattern of co-inhibitory molecules on CMV-specific T-cells in lung transplant patients. Clin Immunol. 2019 Nov; 208: 108258. 3.5
   
4. Buderath P, Schwich E, Jensen C, Horn PA, Kimmig R, Kasimir-Bauer S, Rebmann V. Soluble programmed death receptor ligands sPD-L1 and sPD-L2 as liquid biopsy markers for prognosis and platinum response in epithelial ovarian cancer. Front Oncol. 2019 Oct 15; 9: 1015. 4.1
   
5. Macías M, Rebmann V, Mateos B, Varo N, Perez-Gracia JL, Alegre E, González Á. Comparison of six commercial serum exosome isolation methods suitable for clinical laboratories. Effect in cytokine analysis. Clin Chem Lab Med. 2019 Sep 25; 57(10): 1539-1545. 3.6
   
6. Corso G, Heusermann W, Trojer D, Görgens A, Steib E, Voshol J, Graff A, Genoud C, Lee Y, Hean J, Nordin JZ, Wiklander OPB, El Andaloussi S, Meisner-Kober N. Systematic characterization of extracellular vesicle sorting domains and quantification at the single molecule – single vesicle level by fluorescence correlation spectroscopy and single particle imaging. J Extracell Vesicles. 2019 Sep 18;8(1): 16634043. 11.0
   
7. Lehrnbecher T, Rath PM, Attarbaschi A, Cario G, Döring M, Moser O, Mücke U, Poyer F, Rieken S, Temme C, Voigt S, Groll AH, Lauten M. Galactomannan and PCR in the central nervous system to detect invasive mold disease - A retrospective analysis in immunocompromised children. Sci Rep. 2019 Sep 10; 9(1): 12950. 4.0
   
8. Radtke S, Görgens A, da Conceição Castro SV, Kordelas L, Köninger A, Dürig J, Möllmann M, Horn PA, Giebel B. Human multipotent hematopoietic progenitor cell expansion is neither supported in endothelial and endothelial/mesenchymal co-cultures nor in NSG mice. Sci Rep. 2019 Sep 9; 9(1): 12914. 4.0
   
9. Lauten M, Attarbaschi A, Cario G, Döring M, Moser O, Mücke U, Poyer F, Rieken S, Temme C, Voigt S, Lehrnbecher T, Groll AH. Invasive mold disease of the central nervous system in children and adolescents with cancer or undergoing hematopoietic stem cell transplantation: Analysis of 29 contemporary patients. Pediatr Blood Cancer. 2019 Aug; 66(8): e27806. 2.4
   
10. Rohn H, Michita RT, Schramm S, Dolff S, Gäckler A, Korth J, Heinemann FM,Wilde B, Trilling M, Horn PA, Kribben A, Witzke O, Rebmann V. HLA-E polymorphism determines susceptibility to BK virus nephropathy after living-donor kidney transplant. Cells. 2019 Aug 7; 8(8): 847. 5.7
   
11. Lindemann M, Oesterreich S, Wilde B, Eisenberger U, Muelling N, Horn PA, Heinemann F, Witzke O. Sex-specific differences in HLA antibodies after pneumococcal vaccination in kidney transplant recipients. Vaccines (Basel). 2019 Aug 6; 7(3): 84. 4.8
   
12. Schwich E, Rebmann V, Horn PA, Celik AA, Bade-Döding C, Kimmig R, Kasimir-Bauer S, Buderath P. Vesicular-bound HLA-G as a predictive marker for disease progression in epithelial ovarian cancer. Cancers (Basel). 2019 Aug 2; 11(8): 1106. 6.1
   
13. Ziemann M, Altermann W, Angert K, Arns W, Bachmann A, Bakchoul T, Banas B, von Borstel A, Budde K, Ditt V, Einecke G, Eisenberger U, Feldkamp T, Görg S, Guthoff M, Habicht A, Hallensleben M, Heinemann FM, Hessler N et al. Pre-formed donor-specific HLA antibodies in living and deceased donor transplantation. Clin J Am Soc Nephrol. 2019 Jul 5; 14(7): 1056-1066. 5.8
   
14. Sody S, Uddin M, Grüneboom A, Görgens A, Giebel B, Gunzer M, Brandau S. Distinct spatio-temporal dynamics of tumor-associated neutrophils in small tumor lesions. Front Immunol. 2019 Jun 25; 10: 1419. 4.7
   
15. Domouchtsidou A, Barsegian V, Mueller SP, Lobachevsky P, Best J, Horn PA, Bockisch A, Lindemann M. DNA lesions correlate with lymphocyte function after selective internal radiotherapy. Cancer Immunol Immunother. 2019 Jun; 68(6): 907-915. 4.9
   
16. Karimzadeh H, Kiraithe MM, Oberhardt V, Salimi Alizei E, Bockmann J, Schulze Zur Wiesch J, Budeus B, Hoffmann D, Wedemeyer H, Cornberg M, Krawczyk A, Rashidi-Alavijeh J, Rodríguez-Frías F, Casillas R, Buti M, Smedile A, Alavian SM, Heinold A et al. Mutations in hepatitis D virus allow It to escape detection by CD8+ T cells and evolve at the population level. Gastroenterology. 2019 May; 156(6): 1820-1833. 19.2
   
17. Giebel B, Hermann DM. Identification of the right cell sources for the production of therapeutically active extracellular vesicles in ischemic stroke. Ann Transl Med. 2019 May; 7(9): 188. 3.6
   
18. Cavallaro S, Horak J, Haag P, Gupta D, Stiller C, Sahu S, Görgens A, Gatty HK, Viktorsson K, El Andaloussi S, Lewensohn R, Karlstrom A, Linnros J, Dev A. Label-free surface protein profiling of extracellular vesicles by an electrokinetic sensor. ACS Sens. 2019 May 24; 4(5): 1399-1408. 5.7
   
19. Witwer KW, Van Balkom BWM, Bruno S, Choo A, Dominici M, Gimona M, Hill AF, De Kleijn D, Koh M, Lai RC, Mitsialis SA, Ortiz LA, Rohde E, Asada T, Toh WS, Weiss DJ, Zheng L, Giebel B, Lim SK. Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications. J Extracell Vesicles. 2019 Apr 29; 8(1): 1609206. 11.0
   
20. Brinker TJ, Buslaff F, Suhre JL, Silchmüller MP, Divizieva E, Wilhelm J, Hillebrand G, Penka D, Gaim B, Sowoboda S, Baumermann S, Walther JW, Brieske CM, Jakob L, Baumert HM, Anhuef O, Schmidt SM, Alfitian J, Batra A, aha L, Mons U, Hofmann FJ, Haney AC, Haney CM, Schaible S, Tran TA, Beißwenger H, Stark T, Groneberg DA, Seeger W, Srivastava A, Gall H, Holzapfel J, Rigotti NA, Baudsen TG, Enk AH, Fröhling S, von Kalle C, Bernardes-Souza B, Pereira RMOS, Thomas R. Process Evaluation of a Medical Student-Delivered Smoking Prevention Program for Secondary Schools: Protocol for the Education Against Tobacco Cluster Randomized Trial. JMIR Res Protoc. 2019 Apr 11; 8(4): e13508.  
   
21. Frey UH, Klaassen M, Ochsenfarth C, Murke F, Thielmann M, Kottenberg E, Kleinbongard P, Klenke S, Engler A, Heusch G, Giebel B, Peters J. Remote ischaemic preconditioning increases serum extracellular vesicle concentrations with altered micro-RNA signature in CABG patients. Acta Anaesthesiol Scand. 2019 Apr; 63(4): 483-492. 2.2
   
22. Kordelas L, Schwich E, Dittrich R, Horn PA, Beelen DW, Börger V, Giebel B, Rebmann V. Individual immune-modulatory capabilities of MSC-derived extracellular vesicle (EV) preparations and recipient-dependent responsiveness. Int J Mol Sci. 2019 Apr 2; 20(7): 1642. 4.1
   
23. Schwich E, Rebmann V, Michita RT, Rohn H, Voncken JW, Horn PA, Kimmig R, Kasimir-Bauer S, Buderath P. HLA-G 3' untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer. Sci Rep. 2019 Apr 1; 9(1): 5407. 4.0
   
24. Ricklefs FL, Maire CL, Reimer R, Dührsen L, Kolbe K, Holz M, Schneider E, Rissiek A, Babayan A, Hille C, Pantel K, Krasemann S, Glatzel M, Heiland DH, Flitsch J, Martens T, Schmidt NO, Peine S, Breakefield XO, Lawler S, Chiocca EA, Fehse B, Giebel B, Görgens A, Westphal M, Lamszus K. Imaging flow cytometry facilitates multiparametric characterization of extracellular vesicles in malignant brain tumours. J Extracell Vesicles. 2019 Mar 21; 8(1): 1588555. 11.0
   
25. Görgens A, Bremer M, Ferrer-Tur R, Murke F, Tertel T, Horn PA, Thalmann S, Welsh JA, Probst C, Guerin C, Boulanger CM, Jones JC, Hanenberg H, Erdbrügger U, Lannigan J, Ricklefs FL, El-Andaloussi S, Giebel B. Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material. J Extracell Vesicles. 2019 Mar 21; 8(1): 1587567. 11.0
   
26. Crivello P, Ahci M, Maaßen F, Wossidlo N, Arrieta-Bolaños E, Heinold A, Lange V, Falkenburg JHF, Horn PA, Fleischhauer K, Heinrichs S. Multiple knockout of classical HLA class II β-chains by CRISPR/Cas9 genome editing driven by a single guide RNA. J Immunol. 2019 Mar 15; 202(6): 1895-1903. 4.7
   
27. Roggendorf H, Krawczyk A, Lindemann M, Shouval D, Roggendorf M, Gerken GG. Induction of functional control in chronic hepatitis B patients with low level HBsAg using a combination of a PreS1/S2/S HBV vaccine and a nucleoside analogue. J Infect Dis Ther. 2019; 7(1): 390. 4.3
   
28. Kopp M, Aufderhorst UW, Alt M, Dittmer U, Eis-Hübinger AM, Giebel B, Roggendorf M, Epple M, Krawczyk A. Induction of herpes simplex virus type 1 cell-to-cell spread inhibiting antibodies by a calcium phosphate nanoparticle-based vaccine. Nanomedicine. 2019 Feb; 16: 138-148. 4.7
   
29. Dornieden T, Wilde B, Korth J, Horn PA, Witzke O, Lindemann M. Enhancement of cytomegalovirus-specific cytokine production after modulation of the co-stimulation in kidney transplanted patients. J Immunol Res. 2019 Feb 25; 3926175. 3.4
   
30. Váraljai R, Wistuba-Hamprecht K, Seremet T, Diaz JMS, Nsengimana J, Sucker A, Griewank K, Placke JM, Horn PA, von Neuhoff N, Shannan B, Chauvistré H, Vogel FCE, Horn S, Becker JC, Newton-Bishop J, Stang A, Neyns B, Weide B, Schadendorf D, Roesch A. Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically Heterogeneous Metastatic Melanoma. JCO Precis Oncol. 2019 Feb 15;3:PO.18.00229. doi: 10.1200/PO.18.00229.  
   
31. Lenz V, Wagner B, Baumgart C, Kordelas L, Klingberg CJ, Gebhardt K, Reimer T, Zeiler T, Fischer J, Enczmann J, Balz V, Horn PA. BluStar.NRW - a project for typing refugees and migrants as potential blood and stem cell donors. Oncology Research and Treatment. 2019; 42 Suppl 4: 234. 2.0
   
32. van Balkom BW, Gremmels H, Giebel B, Lim SK. Proteomic signature of mesenchymal stromal cell-derived small extracellular vesicles. Proteomics. 2019 Jan; 19(1-2): e1800163. 3.1
   
33. Gussenhoven R, Klein L, Ophelders DRMG, Habets DHJ, Giebel B, Kramer BW, Schurgers LJ, Reutelingsperger CPM, Wolfs TGAM. Annexin A1 as Neuroprotective Determinant for Blood-Brain Barrier Integrity in Neonatal Hypoxic-Ischemic Encephalopathy. J Clin Med. 2019 Jan 24; 8(2): 137. 5.6
   
Humpe A, Korper S, Schafer R, Klump H, Worel N. The role of Transfusion Medicine Departments in the Process of Implementing Approved CAR-T Cell Therapies. Transfusionsmedizin. 2019;9(3): 168-172. [Buchbeitrag]  
   
2018 Impact Factor
1. Neureiter A, Brändl B, Hiber M, Tandon R, Müller FJ, Steenpass L. Generation of an iPSC line of a patient with Angelman syndrome due to an imprinting defect. Stem Cell Res. 2018 Dec; 33:20-24. doi: 10.1016/j.scr.2018.09.015. 4.4
   
2. Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK, Ayre DC, Bach JM, Bachurski D, Baharvand H, Balaj L, Baldacchino S, Bauer NN, Baxter AA, Bebawy M, Beckham C, Bedina Zavec A, Benmoussa A, Berardi AC, Bergese P, Bielska E, Blenkiron C, Bobis-Wozowicz S, Boilard E, Boireau W, Bongiovanni A, ..., Giebel B, Gilbert C, Gimona M, Giusti I, Goberdhan DC, Görgens A et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018 Nov 23; 7(1): 1535750. 11.0
   
3. Brinker TJ, Buslaff F, Haney C, Gaim B, Haney AC, Schmidt SM, Silchmüller MP, Taha L, Jakob L, Baumert HM, Hallmann M, Heckl M, Alfitian J, Brieske CM, Divizieva EP, Wilhelm J, Hillebrand G, Penka D, Raveendranathan S; Netzwerk Aufklärung gegen Tabak, Suhre JL. Das weltweite Medizinernetzwerk Aufklärung gegen Tabak – Ehrenamtliche Prävention made in Germany [The global medical network Education Against Tobacco-voluntary tobacco prevention made in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Nov;61(11):1453-1461. German. doi: 10.1007/s00103-018-2826-8. 0.9
   
4. Gliga S, Korth J, Krawczyk J, Wilde B, Horn PA, Witzke O, Lindemann M*, Fiedler M*. T-Track-CMV and QuantiFERON-CMV assays for prediction of protection from CMV reactivation in kidney transplant recipients. *equal contribution. J Clin Virol. 2018 Aug; 105: 91-96. 3.0
   
5. Wiklander OPB, Bostancioglu RB, Welsh JA, Zickler AM, Murke F, Corso G, Felldin U, Hagey DW, Evertsson B, Liang XM, Gustavsson MO, Mohammad DK, Wiek C, Hanenberg H, Bremer M, Gupta D, Björnstedt M, Giebel B, Nordin JZ, Jones JC, El Andaloussi S, Görgens A. Systematic Methodological Evaluation of a Multiplex Bead-Based Flow Cytometry Assay for Detection of Extracellular Vesicle Surface Signatures. Front. Immunol. 2018 Jun 13; 9: 1326. 5.7
   
6. Lindemann M, Eiz-Vesper B, Steckel NK, Tischer S, Fiedler M, Heinold A, Klisanin V, Maecker-Kolhoff B, Blasczyk R, Horn PA, Beelen DW, Koldehoff M. Adoptive transfer of cellular immunity against cytomegalovirus by virus-specific lymphocytes from a third party family donor. Bone Marrow Transplant. 2018 May 08; 53(10): 1351-1355. 4.7
   
7. Buechter M, Manka P, Heinemann FM, Lindemann M, Baba HA, Schlattjan M, Canbay A, Gerken G, Kahraman A. Potential triggering factors of acute liver failure as a first manifestation of autoimmune hepatitis-a single center experience of 52 adult patients. World J Gastroenterol. 2018 Apr 7; 24(13): 1410-1418. 3.4
   
8. Domouchtsidou A, Barsegian V, Mueller SP, Best J, Ertle J, Bedreli S, Horn PA, Bockisch A, Lindemann M. Impaired lymphocyte function in patients with hepatic malignancies after selective internal radiotherapy. Cancer Immunol Immunother. 2018 May; 67(5): 843-853. 4.9
   
9. Danielzik T, Koldehoff M, Buttkereit U, Beelen DW, Horn PA, Lindemann M. Sensitive detection of rare antigen specific T cells directed against Wilms’ tumor 1 by FluoroSpot assay. Leuk Lymphoma. 2018 Feb; 59(2): 490-492. 2.7
   
10. Velardi E, Tsai JJ, Radtke S, Cooper K, Argyropoulus KV, Jae-Hung S, Young LF, Lazrak A, Smith OM, Liebermann S, Kreines F, Shono F, Wertheimer T, Jenq RR, Hanash AM, Narayan P, Lei Z, Moore MA, Kiem HP, van den Brink MRM, Dudakov JA. Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injury. Nature Medicine. 2018 Jan 08; 24(2): 239-246. 29.8
   
11. Thivakaran A, Botezatu L, Hönes JM, Schütte J, Vassen L, Al-Matary YS, Patnana P, Zeller A, Heuser M, Thol F, Gabdoulline R, Olberding N, Frank D, Suslo M, Köster R, Lennartz K, Görgens A, Giebel B, Opalka B, Dührsen U, Khandanpour C; no. Growth factor independence 1b. A key player in the genesis and maintenance of acute myeloid leukaemia and myelodysplastic syndrome. Haematologica. 2018 Apr; 103(4): 614-625. 7.7
   
12. Teichweyde N, Kasperidus L, Carotta S, Kouskoff V, Lacaud G, Horn PA, Heinrichs S, Klump H. HOXB4 Promotes Hemogenic Endothelium Formation without Perturbing Endothelial Cell Development. Stem Cell Reports. 2018 Mar 13; 10(3): 875-889. 7.3
   
13. Koldehoff M, Lindemann M, Ross SR, Elmaagacli AH. Cytomegalovirus induces HLA-class-II-restricted alloreactivity in an acute myeloid leukemia cell line. PLoS One. 2018; 13(1): e0191482. 2.8
   
14. Kordelas L, da Silva Nardi F, Wagener B, Ditschkowski M, Liebregts T, Lindemann M, Heinemann FM, Horn PA, Beelen DW, Rebmann V. Elevated soluble human leukocyte antigen G levels in patients after allogeneic stem cell transplantation are associated with less severe acute and chronic graft-versus-host disease. Bone Marrow Transplant. 2018 Sep; 53(9): 1149-1156. 4.7
   
15. Banas B, Chittka D, Banas MC, Steubl D, Renders L, Wekerle T, Koch M, Witzke O, Mühlfeld A, Sommerer C, Habicht A, Hugo C, Hünig T, Lindemann M, Schmidt T, Rascle A, Barabas S, Deml L, Wagner R, Krüger B, Krämer BK. Clinical validation of T-Track® CMV to monitor CMV-specific cell-mediated immunity in kidney transplant recipients. Transpl Int. 2018; 31: 436-450. 3.1
   
16. Arnold ML, Bach C, Heinemann FM, Horn PA, Ziemann M, Lachmann N, Mühlbacher A, Dick A, Ender A, Thammanichanond D, Schaub S, Hönger G, Fischer GF, Mytilineos J, Hallensleben M, Hitzler WE, Seidl C, Spriewald BM. Anti-HLA alloantibodies of the IgA isotype in re-transplant candidates part II: Correlation with graft survival. Int J Immunogenet. 2018 Jun; 45(3): 95-101. 1.1
   
17. Doeppner TR, Bähr M, Giebel B Hermann DB. Immunological and non-immunological effects of stem cell-derived extracellular vesicles on the ischaemic brain. Ther Adv Neurol Disord. 2018 Jul 26; 11: 1756286418789326. 3.5
   
18. Rohn H, Tomoya Michita R, Schwich E, Dolff S, Gäckler A, Trilling M, Le-Trilling VTK, Wilde B, Korth J, Heinemann FM, Horn PA, Kribben A, Witzke O, Rebmann V. The Donor Major Histocompatibility Complex Class I Chain-Related Molecule A Allele rs2596538 G Predicts Cytomegalovirus Viremia in Kidney Transplant Recipients. Front Immunol. 2018; 9: 917. 5.5
   
19. Schwich E, Rebmann V. The Inner and Outer Qualities of Extracellular Vesicles for Translational Purposes in Breast Cancer. Front Immunol. 2018 Mar 26; 9: 584. 5.5
   
20. Lipps C, Klein F, Wahlicht T, Seiffert V, Butueva M, Zauers J, Truschel T, Luckner M, Köster M, MacLeod R, Pezoldt J, Hühn J, Yuan Q, Müller PP, Kempf H, Zweigerdt R, Dittrich-Breiholz O, Pufe T, Beckmann R, Drescher W, Riancho J, Sañudo C, Korff T, Opalka B, Rebmann V, Göthert JR, Alves PM, Ott M, Schucht R, Hauser H, Wirth D, May T. Expansion of functional personalized cells with specific transgene combinations. Nat Commun. 2018 Mar 8; 9(1): 994. 12.4
   
21. Babay W, Ben Yahia H, Boujelbene N, Zidi N, Laaribi AB, Kacem D, Ben Ghorbel R, Boudabous A, Ouzari HI, Rizzo R, Rebmann V, Mrad K, Zidi I. Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma. Hum Immunol. 2018 Jun; 79(6): 463-470. 2.0
   
22. Thoens C*, Heinold A*, Lindemann M, Horn PA, Scherbaum N, Timm J, Heinemann FM (2018): A single nucleotide polymorphism upstream of the HLA-C locus is associated with an anti-HCV seronegative state in a high-risk exposed cohort. *both authors contributed equally. J Infect Dis. 2018 Nov 5; 218(12): 2016-2019. 6.3
   
23. Michita RT, Chies JAB, Schramm S, Horn PA, Heinemann FM, Wunsch A, Viebahn R, Schenker P, Rebmann V. A Valine Mismatch at Position 129 of MICA Is an Independent Predictor of Cytomegalovirus Infection and Acute Kidney Rejection in Simultaneous Pancreas-Kidney Transplantation Recipients. Int J Mol Sci. 2018; 19(9): 2618. pii: E2618. doi: 10.3390/ijms19092618. 3.6
   
24. Fathi NN, Mohammad DK, Görgens A, Andaloussi SE, Zain R, Nore BF, Smith CIE. Translocation-generated ITK-FER and ITK-SYK fusions induce STAT3 phosphorylation and CD69 expression. Biochemical and Biophysical Research Communications. 2018; 504(4): 749-752. 2.6
   
25. Huetter FK, Horn PA, Siffert W. Sex-specific association of a common GNAS polymorphism with self-reported cognitive empathy in healthy volunteers. PLoS One. 2018 Oct 26; 13(10): e0206114. 2.7
   
26. Ludwig AK, De Miroschedji K, Doeppner TR, Börger V, Ruesing J, Rebmann V, Durst S, Jansen S, Bremer M, Behrmann E, Singer BB, Jastrow H, Kuhlmann JD, El Magraoui F, Meyer HE, Hermann DM, Opalka B, Raunser S, Epple M, Horn PA, Giebel B. Precipitation with polyethylene glycol followed by washing and pelleting by ultracentrifugation enriches extracellular vesicles from tissue culture supernatants in small and large scales. J Extracell Vesicles. 2018 Oct 17; 7(1): 1528109. doi: 10.1080/20013078.2018.1528109. 11.0
   
27. Hummel EM, Hessas E, Müller S, Beiter T, Fisch M, Eibl A, Wolf OT, Giebel B , Platen P, Kumsta R, Moser DA. Cell-free DNA release under psychosocial and physical stress conditions. Translational Psychiatry. 2018 Oct 29; 8(1): 236. 5.1
   
28. Lindemann M, Korth J, Sun M, Xu S, Struve C, Werner K, Dornieden T, Horn PA, Witzke O, Wilde B. The Cytomegalovirus-Specific IL-21 ELISpot Correlates with Allograft Function of Kidney Transplant Recipients. Int J Mol Sci. 2018 Dec 8; 19(12): 3945. 3.7
   
29. Lindemann M, Lenz V, Nyadu B, Heinemann FM, Heinold A, Guberina H, Eisenberger U, Lachmann N, Schönemann C, Kribben A, Paul A, Horn PA, Witzke O. Effect of ABO incompatibility on T cell flow cytometry crossmatch results prior to living donor kidney transplantation. Cytometry B Clin Cytom. 2018 Jul; 94(4): 623-630. 2.8
   
30. Ayuk F, Beelen DW, Bornhäuser M, Stelljes M, Zabelina T, Finke J, Kobbe G, Wolff D, Wagner EM, Christopeit M, Schmid C, Ottinger H, Groth C, Faul C, Bertz H, Rachlis E, Wolschke C, Schetelig J, Horn PA, Mytilineos J, Guellstorf M, Kelsch R, Fleischhauer K, Kröger N, Bethge W. Relative Impact of HLA Matching and Non-HLA Donor Characteristics on Outcomes of Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome. Biol Blood Marrow Transplant. 2018 Dec; 24(12): 2558-2567. 4.5
   
31. Röth A, Bommer M, Hüttmann A, Herich-Terhürne D, Kuklik N, Rekowski J, Lenz V, Schrezenmeier H, Dührsen U. Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial. Blood Adv. 2018 Oct 9; 2(19): 2543-2549.  
   
32. Arrieta-Bolaños E, Crivello P, Metzing M, Meurer T, Ahci M, Rytlewski J, Vignali M, Yusko E, van Balen P, Horn PA, Falkenburg JHF, Fleischhauer K. Alloreactive T Cell Receptor Diversity against Structurally Similar or Dissimilar HLA-DP Antigens Assessed by Deep Sequencing. Front Immunol. 2018 Feb 19; 9: 280. 5.5
   
33. Landsberg CD, Megger DA, Hotter D, Rückborn MU, Eilbrecht M, Rashidi-Alavijeh J, Howe S, Heinrichs S, Sauter D, Sitek B, Le-Trilling VTK, Trilling M. A Mass Spectrometry-Based Profiling of Interactomes of Viral DDB1- and Cullin Ubiquitin Ligase-Binding Proteins Reveals NF-KB Inhibitory Activity of the HIV-2-Encoded Vpx. Front Immunol. 2018 Dec 19; 9: 2978. 5.5
   
34. Meurer T, Arrieta-Bolaños E, Metzing M, Langer MM, van Balen P, Falkenburg JHF, Beelen DW, Horn PA, Fleischhauer K, Crivello P. Dissecting Genetic Control of HLA-DPB1 Expression and Its Relation to Structural Mismatch Models in Hematopoietic Stem Cell Transplantation. Front Immunol. 2018 Oct 5; 9: 2236. 5.5
   
35. Guberina H, da Silva Nardi F, Michita RT, Dolff S, Bienholz A, Heinemann FM, Wilde B, Trilling M, Horn PA, Kribben A, Witzke O, Rebmann V. Susceptibility of HLA-E*01:03 Allele Carriers to Develop Cytomegalovirus Replication After Living-Donor Kidney Transplantation. J Infect Dis. 2018 May 25; 217(12): 1918-1922. 5.2
   
36. Karimzadeh H, Kiraithe MM, Kosinska AD, Glaser M, Fiedler M, Oberhardt V, Salimi Alizei E, Hofmann M, Mok JY, Nguyen M, van Esch WJE, Budeus B, Grabowski J, Homs M, Olivero A, Keyvani H, Rodríguez-Frías F, Tabernero D, Buti M, Heinold A, Alavian SM, Bauer T, Schulze Zur Wiesch J, Raziorrouh B, Hoffmann D, Smedile A, Rizzetto M, Wedemeyer H, Timm J, Antes I, Neumann-Haefelin C, Protzer U, Roggendorf M. Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8 T Cells. J Virol. 2018 Jun 13; 92(13: e01891-17. 4.4
   
37. Friebus-Kardash J, Wilde B, Keles D, Heinold A, Kribben A, Witzke O, Heinemann FM, Eisenberger U. Pretransplant serum BAFF levels are associated with pretransplant HLA immunization and renal allograft survival. Transpl Immunol. 2018 Apr; 47: 10-17. 1.7
   
38. Banas B, Steubl D, Renders L, Chittka D, Banas MC, Wekerle T, Koch M, Witzke O, Mühlfeld A, Sommerer C, Habicht A, Hugo C, Hünig T, Lindemann M, Schmidt T, Rascle A, Barabas S, Deml L, Wagner R, Krämer BK, Krüger B. Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study. Transpl Int. 2018 Apr; 31(4): 436-450. doi: 10.1111/tri.13110. 3.5
   
39. Stanurova J, Neureiter A, Hiber M, de Oliveira Kessler H, Stolp K, Goetzke R, Klein D, Bankfalvi A, Klump H, Steenpass L. Corrigendum: Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing. Sci Rep. 2018 Mar 8; 8: 46952. doi: 10.1038/srep46952. 4.0
   
40. Brinker TJ, Brieske CM, Esser S, Klode J, Mons U, Batra A, Rüther T, Seeger W, Enk AH, von Kalle C, Berking C, Heppt MV, Gatzka MV, Bernardes-Souza B, Schlenk RF, Schadendorf D. A Face-Aging App for Smoking Cessation in a Waiting Room Setting: Pilot Study in an HIV Outpatient Clinic. J Med Internet Res. 2018 Aug 15; 20(8): e10976. doi: 10.2196/10976. 5.0
   
41. Lehrnbecher T, Groll A, Agyeman P, Ammann RA, Attarbaschi A, Behrends U, Berger C, Hamprecht A, Hufnagel M, Laws HJ, Scheler M, Temme C, Vieth S, Simon A. Empfehlungen zur Diagnostik und Therapie bei krebskranken Kindern mit Fieber und Neutropenie – Vergleich zweier aktueller Leitlinien [Recommendations for Diagnostics and Therapy of Children with Cancer Presenting with Fever and Neutropenia - Comparison of Two Current Guidelines]. Klin Padiatr. 2018 Apr; 230(3): 115-121. German. doi: 10.1055/s-0044-101953. 0.9
2017 Impact Factor
1. Steens J, Zuk M, Benchellal M, Bornemann L, Teichweyde N, Hess J, Unger K, Görgens A, Klump H and Klein D. In Vitro Generation of Vascular Wall-Resident Multipotent Stem Cells of Mesenchymal Nature from Murine Induced Pluripotent Stem Cells. Stem Cell Reports. 2017 Apr 11;8(4): 919-932. 7.3
   
2. Willuweit K, Heinold A, Rashidi-Alavijeh J, Heinemann FM, Horn PA, Paul A, Gerken G, Herzer K. Immunosuppression with mTOR inhibitors prevents the development of donor-specific antibodies after liver transplant. Clin Transplant. 2017 Jun;31(6). 1.8
   
3. Ziemann M, König IR, Lachmann N, Dick A, Ditt V, Budde K, Reinke P, Eisenberger U, Suwelack B, Klein T, Westhoff TH, Arns W, Ivens K, Habicht A, Stippel D, Bös D, Nitschke M, Feldkamp T, Heinemann FM* and Kelsch R*. Unacceptable human leucocyte antigens for organ offers in the era of organ shortage: Influence on waiting time before kidney transplantation. Nephrol Dial Transplant. 2017 May 1; 32(5): 880-889. 4.1
   
4. Giebel B. On the function and heterogeneity of extracellular vesicles. Ann Transl Med. 2017 Mar; 5(6): 150. 3.6
   
5. Becker J, Horn PA, Keyvani K, Metz I, Wegner C, Brück W, Heinemann FM, Schwitalla JC, Berlit P, Kraemer M. Primary Central Nervous System Vasculitis and its mimicking diseases − clinical features, outcome, comorbidities and diagnostic results − a case control study. Clin Neurol Neurosurg. 2017 May; 156: 48-54. 1.2
   
6. Thöns C, Senff T, Hydes T, Manser A, Heinemann FM, Heinold A, Heilmann M, Kim AY, Uhrberg M, Scherbaum N, Lauer GM, Khakoo SI, Timm J. HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs. J Hepatol. 2017 Sep; 67(3): 462-470. 10.6
   
7. Buechter M, Manka P, Heinemann FM, Lindemann M, Juntermanns B, Canbay A, Gerken G and Kahraman A. Outcome and Genetic Factors in IgG4-Associated Autoimmune Pancreatitis and Cholangitis: A Single Center Experience. Gastroenterol Res Pract. 2017; 2017:6126707. doi: 10.1155/2017/6126707. Epub 2017 Mar 2. 1.7
   
8. EV-TRACK Consortium, Van Deun J, Mestdagh P, [...], Bremer M, [...], Giebel B, [...] Hendrix A. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nature Methods. 2017 Feb 28; 14: 228–232. 25.3
   
9. Drommelschmidt K, Serdar M, Bendix I, Herz J, Bertling F, Prager S, Keller M, Ludwig AK, Duhan V, Radtke S, de Miroschedji K, Horn PA, van de Looij Y, Giebel B, Felderhoff-Müser U. Mesenchymal stem cell-derived extracellular vesicles ameliorate inflammation-induced preterm brain injury. Brain Behav Immun. 2017; 60: 220-232. 6.0
   
10. O'Driscoll L, Stoorvogel W, Théry C, Buzas E, Nazarenko I, Siljander P, Yáñez-Mó M, Fais S, Giebel B, Yliperttula M. European Network on Microvesicles and Exosomes in Health and Disease (ME-HaD). Eur J Pharm Sci. 2017 Feb 15; 98: 1-3. 3.8
   
11. Kordelas L, Buttkereit U, Lindemann M, Koldehoff M, Klisanin V, Horn PA, Fleischhauer K, Dietrich W. Beelen DW. αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation. Bone Marrow Transplant. 2017; 52(12): 1668-1670. 3.9
   
12. Jiqiaoa Z, Yenga Z, Dolff S, Bienholz A, Lindemann M, Brinkhoff A, Schedlowski M, Xua S, Suna M, Guberina H, Kirchhof J, Kribben A, Witzke O, Wilde B. Granzyme B producing B-cells in renal transplant patients. Clin Immunol. 2017; 184: 48-53. 4.0
   
13. Lindemann M, Zaslavskaya M, Fiedler M, Wilde B, Heinemann FM, Heinold A, Horn PA, Witzke O. Humoral and cellular responses to a single dose of Fendrix in renal transplant recipients with non-response to previous hepatitis B vaccination. Scand J Immunol. 2017 Jan; 85(1): 51-57. 2.3
   
14. Barsegian V, Müller SP, Möckel D, Horn PA, Bockisch A, Lindemann M. Lymphocyte function following radium-223 therapy in patients with metastasized, castration resistant prostate cancer. Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):242-246. 7.2
   
15. Reiner AT, Witwer KW, van Balkom BWM, de Beer J, Brodie C, Corteling RL, Gabrielsson S, Gimona M, Ibrahim AG, de Kleijn D, Lai CP, Lötvall J, Del Portillo HA, Reischl IG, Riazifar M, Salomon C, Tahara H, Toh WS, Wauben MHM, Yang VK, Yang Y, Yeo RWY, Yin H, Giebel B, Rohde E, Lim SK. Concise Review: Developing Best-Practice Models for the Therapeutic Use of Extracellular Vesicles. Stem Cells Transl Med. 2017 Aug; 6(8):1730-1739. 4.2
   
16. Börger V, Bremer M, Ferrer-Tur R, Gockeln L, Stambouli O, Becic A, Giebel B. Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles and Their Potential as Novel Immunomodulatory Therapeutic Agents. Int J Mol Sci. 2017 Jul 6; 18(7): 1450. 3.2
   
17. Kraemer M, Becker J, Horn PA, Schwitalla JC, Keyvani K, Metz I, Wegner C, Brück W, Schlamann M, Heinemann FM*, Berlit P*. Association of primary central nervous system vasculitis with the presence of specific human leucocyte antigen gene variant. Clin Neurol Neurosurg. 2017 Sep; 160: 137-141. 1.4
   
18. Ahci M, Stempelmann K, Buttkereit U, Crivello P, Trilling M, Heinold A, Steckel NK, Koldehoff M, Horn PA, Beelen DW, Fleischhauer K. Clinical Utility of Quantitative PCR for Chimerism and Engraftment Monitoring after Allogeneic Stem Cell Transplantation for Hematologic Malignancies. Biol Blood Marrow Transplant. 2017 Oct; 23(10): 1658-1668. 4.7
   
19. Giebel B, Helmbrecht C. Methods to Analyze EVs. Methods Mol Biol. 2017; 1545:1-20.  
   
20. Giebel B, Kordelas L, Börger V. Clinical potential of mesenchymal stem/stromal cell-derived extracellular vesicles. Stem Cell Investig. 2017 Oct 24; 4:84. doi: 10.21037/sci.2017.09.06. eCollection 2017. Review. PMID: 29163407.  
   
21. Radtke S, Adair JE, Giese MA, Chan Y, Norgaard ZK, Enstrom M, Haworth KG, Schefter LE, Kiem HP. A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates. Science Translational Medicine. 2017 Nov 1; 9(414): eaan1145. 16.7
   
22. Langer S, Horn PA, Heinrichs S. From Stem Cell Research to Three-Dimensional Organoids and Their Applications in Cancer Research. Cellular Reprogramming. 2017 Oct; 19(5): 285-288. 1.3
   
23. Guberina H, Tomoya Michita R, Dolff S, Bienholz A, Trilling M, Heinemann FM, Horn PA, Kribben A, Witzke O, Rebmann V. Recipient HLA-G +3142 CC Genotype and Concentrations of Soluble HLA-G Impact on Occurrence of CMV Infection after Living-Donor Kidney Transplantation. Int J Mol Sci. 2017 Nov 5;18(11):2338. 3.2
   
24. Heinemann FM*, Jindra PT*, Bockmeyer CL, Zeuschner P, Wittig J, Höflich H, Eßer M, Abbas M, Dieplinger G, Stolle K, Vester U, Hoyer PF, Immenschuh S, Heinold A, Horn PA, Li W, Eisenberger U, Becker JU. Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo. Sci Rep. 2017 Nov 6;7(1):14554. *contributed equally 4.3
   
25. Lindemann M, Heinold A, Lenz V, Horn PA, Heinemann FM . The flow cytometric crossmatch – a more sensitive prediction of transplant rejections. Transfus Med 2017; 7: 233-237. 1.6
   
26. Dietrich L, Rathmer B, Ewan K, Bange T, Heinrichs S, Dale TC, Schade D, Grossmann TN. Cell Permeable Stapled Peptide Inhibitor of Wnt Signaling that Targets β-Catenin Protein-Protein Interactions. Cell Chem Biol. 2017 Aug 17; 24(8): 958-968. 4.5
   
27. Teichweyde N, Horn PA, Klump H. HOXB4 Increases Runx1 Expression to Promote the de novo Formation of Multipotent Hematopoietic Cells. Transfus Med Hemother. 2017 Jun; 44(3): 128-134. 1.4
   
28. Guberina H, Rebmann V, Wagner B, da Silva Nardi F, Dziallas P, Dolff S, Bienholz A, Wohlschlaeger J, Bankfalvi A, Heinemann FM, Witzke O, Zoet YM, Claas FH, Horn PA, Kribben A, Doxiadis II. Association of high HLA-E expression during acute cellular rejection and numbers of HLA class I leader peptide mismatches with reduced renal allograft survival. Immunobiology. 2017 Mar; 222(3): 536-543. 2.7
   
29. Wagner B, da Silva Nardi F, Schramm S, Kraemer T, Celik AA, Dürig J, Horn PA, Dührsen U, Nückel H, Rebmann V. HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia. Cancer. 2017 Mar 1; 123(5): 814-823. 6.1
   
30. Bauer D, Alt M, Dirks M, Buch A, Heilingloh CS, Dittmer U, Giebel B, Görgens A, Palapys V, Kasper M, Eis-Hübinger AM, Sodeik B, Heiligenhaus A, Roggendorf M, Krawczyk A. A Therapeutic Antiviral Antibody Inhibits the Anterograde Directed Neuron-to-Cell Spread of Herpes Simplex Virus and Protects against Ocular Disease. Front Microbiol. 2017 Oct 31; 8 :2115. 4.0
   
31. Hönes JM, Thivakaran A, Botezatu L, Patnana P, Castro SVDC, Al-Matary YS, Schütte J, Fischer KBI, Vassen L, Görgens A, Dührsen U, Giebel B, Khandanpour C. Enforced GFI1 expression impedes human and murine leukemic cell growth. Sci Rep. 2017 Nov 16; 7(1): 15720. 4.2
   
32. Doeppner TR, Bähr M, Hermann DM, Giebel B. Concise Review: Extracellular Vesicles Overcoming Limitations of Cell Therapies in Ischemic Stroke. Stem Cells Transl Med. 2017 Nov; 6(11): 2044-2052. 4.0
   
33. Corso G, Mäger I, Lee Y, Görgens A, Bultema J, Giebel B, Wood MJA, Nordin JZ, Andaloussi SE. Reproducible and scalable purification of extracellular vesicles using combined bind-elute and size exclusion chromatography. Sci Rep. 2017 Sep 14; 7(1): 11561. 4.2
   
34. Adair JE, Radtke S, Norgaard ZK, Haworth KG, Schefter LE, Giese MA, Chan YY, Kiem HP. Early and Stable Engraftment of a Population of Highly-Enriched Long-Term Multi-Potent Hematopoietic Stem Cells. Mol Ther. 2017; 25 1(5): 339-339. 7.0
   
35. Ferrer-Tur R, Gorgens A, Borger V, Horn PA, Giebel B. Mesenchymal stem/stromal cells release different subtypes of extracellular vesicles. Transfus Med Hemother. 2017; 44 1: 86-87. 2.2
   
36. Murke F, Gorgens A, Horn PA, Giebel B. Dissecting the origin of dendritic cell and macrophage subsets in human hematopoiesis. Transfus Med Hemother. 2017; 44 1: 73-73. 2.2
   
37. König L, Kasimir-Bauer S, Bittner AK, Hoffmann O, Wagner B, Santos Manvailer LF, Kimmig R, Horn PA, Rebmann V. Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy. Oncoimmunology. 2017 Sep 27; 7(1): e1376153. 5.5
   
38. König L, Kasimir-Bauer S, Bittner AK, Hoffmann O, Wagner B, Manveiler LFS, Kimmig R, Horn PA, Rebmann V. Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy. OncoImmunology. 2017 Sep 27; 7(1): e1376153. 5.3
   
39. Andreas Scharberg EA, Huck R, Leimkühler K, Lenz V, Breyer M, Bugert P. Serological and Molecular Diagnostics in a Patient with Multiple Red Cell Antibodies and Anti-Tc(a). 2017; 7(03): 162-166. doi: 10.1055/s-0043-105033.  
   
2016 Impact Faktor
1. Zhao F, Lübcke S, Sucker A, Fatho M, Horn S, Heeke C, Bielefeld N, Lindemann M, Stiller M, Becker JC, Lennerz V, Schadendorf D, Griewank K, Wölfel T, Paschen A. Melanoma lesions independently acquire T-cell resistance during metastatic latency. Cancer Res. 2016 Aug 1; 76(15): 4347-4358. 9.3
   
2. Kordelas L, Steckel NK, Horn PA, Beelen DW, Rebmann V. The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease. Int J Mol Sci. 2016 Oct 27; 17(11): 1797. 3.2
   
3. Luckau S, Wehrs TP, Brandau S, Horn PA, Lindemann M. Vaccination against human papilloma viruses leads to a favorable cytokine profile of specific T cells. J Immunother. 2016 Oct; 39(8): 316-320. 3.7
   
4. Stanurova J, Neureiter A, Hiber M, de Oliveira Kessler H, Stolp K, Goetzke R, Klein D, Bankfalvi A, Klump H, Steenpass L. Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing. Nature Scientific Reports. 2016 Aug 3; 6: 30792. 5.5
   
5. Nardi Fda S, König L, Wagner B, Giebel B, Santos Manvailer LF, Rebmann V. Soluble monomers, dimers and HLA-G-expressing extracellular vesicles: the three dimensions of structural complexity to use HLA-G as a clinical biomarker. HLA. 2016 Sep; 88(3): 77-86. 2.7
   
6. Rashidi-Alavijeh J, Heinold A, Willuweit K, Baba HA, Horn PA, Paul A, Witzke O, Gerken G, Herzer K. Diagnostics and treatment of a severe humoral rejection after liver transplantation: donor-specific antibodies as a still underestimated cause of graft failure. Z Gastroenterol. 2016 Jul; 54(7): 647-652. 1.6
   
7. Mertens A, Brandl C, Miron-Shatz T, Schlick C, Neumann T, Kribben A, Meister S, Jonas Diamantidis C, Albrecht UV, Horn PA, Becker S. A mobile application improves therapy-adherence rates in elderly patients undergoing rehabilitation: A crossover design study comparing documentation via iPad with paper-based control. Medicine (Baltimore). 2016 Sep; 95(36): e4446. 4.3
   
8. Goergens A. Analysis of extracellular vesicles including exosomes by imaging flow cytometry. Science. 2016 Jun 03; 352(6290): 1238.  
   
9. Görgens A, Murke F, Kordelas L, Giebel B. Lost in Transplantation? Unexpected shift from multipotent to late lymphomyeloid hematopoietic stem and progenitor cells in patients 1 year after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2016 Aug; 51(8): 1073-1075. 3.6
   
10. Botezatu L, Michel LC, Helness A, Vadnais C, Hönes JM, Makishima H, Robert F, Vassen L, Aniththa Thivakaran1, Al-Matary Y, Lams RF, Schütte J, Giebel B, Görgens A, Heuser M, Medyouf H, Maciejewski J, Dührsen U, Möröy T,Khandanpour C. Epigenetic therapy as a novel approach for GFI136N-associated murine/human AML. Exp. Hematol. 2016 Aug; 44(8): 713-726. 2.5
   
11. Huetter FK, Bachmann HS, Reinders A, Siffert D, Stelmach P, Knop D, Horn PA, Siffert W. Association of a Common Oxytocin Receptor Gene Polymorphism with Self-Reported 'Empathic Concern' in a Large Population of Healthy Volunteers. PLoS One. 2016 Jul 28; 11(7): e0160059. 2.9
   
12. Nardi F da S, Michelon TF, Neumann J, Manvailer LF, Wagner B, Horn PA, Bicalho Mda G, Rebmann V. High levels of circulating extracellular vesicles with altered expression and function during pregnancy. Immunobiology. 2016 Jul; 221(7): 753-760. 2.8
   
13. Crivello P, Heinold A, Rebmann V, Ottinger HD, Horn PA, Beelen DW, Fleischhauer K. Functional distance between recipient and donor HLA-DPB1 determines non-permissive mismatches in unrelated HCT. Blood. 2016 Jul 7; 128(1): 120-129. 11.8
   
14. Rebmann V, König L, da Silva Nardi F, Wagner B, dos Santos Manvailer LF and Horn PA. The Potential of HLA-G-Bearing Extracellular Vesicles as a Future Element in HLA-G Immune Biology. Front. Immunol. 2016 May 04. 5.7
   
15. Ophelders DRMG, Wolfs TGAM, Jellema RK, Zwanenburg A, Andriessen P, Delhaas T, Ludwig AK, Radtke S, Peters V, Janssen L, Giebel B and Kramer BW. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Protect the Fetal Brain After Hypoxia-Ischemia. Stem Cells Transl Med. 2016 Jun; 5(6): 754-763. 5.7
   
16. Hombach AA, Görgens A, Chmielewski M, Murke F, Kimpel J, Giebel B, Abken H. Superior therapeutic index in lymphoma therapy: CD30+ CD34+ hematopoietic stem cells resist a chimeric antigen receptor (CAR) T cell attack. Mol Ther. 2016 Aug; 24(8): 1423-1434. 6.2
   
17. Nel I, Gauler TC, Bublitz K, Lazaridis L, Goergens A, Giebel B, Schuler M, Hoffmann AC. Circulating Tumor Cell Composition in Renal Cell Carcinoma. PLoS One. 2016 Apr; 11(4): e0153018. 3.5
   
18. Radtke S, Haworth KG, Kiem HP. The frequency of multipotent CD133+CD45RA−CD34+ hematopoietic stem cells is not increased in fetal liver compared with adult stem cell sources. Exp. Hematology. 2016 Jun; 44(6): 502-507. 2.5
   
19. Lindemann M, Könemann J, Horn PA, Witzke O. IL-17 ELISpot as Predictor for Kidney Allograft Rejection? Clin Lab. 2016; 62(5): 963-965. 1.1
   
20. Fais S, O’Driscoll L, Borras FE, Buzas E, Camussi G, Cappello F, Carvalho J, Cordeiro da Silva A, Del Portillo H, El Andaloussi S, Ficko Trček T, Furlan R, Hendrix A, Gursel I, Kralj-Iglic V, Kaeffer B, Kosanovic M, Lekka ME, Lipps G, Logozzi M, Marcilla A, Sammar M, Llorente A, Nazarenko I, Oliveira C, Pocsfalvi G, Rajendran L, Raposo G, Rohde E, Siljander P, van Niel G, Vasconcelos MH, Yáñez-Mó M, Yliperttula ML, Zarovni N, Zavec AB and Giebel B. Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine. ACS Nano. 2016 Apr 26; 10(4): 3886-3899. 12.9
   
21. Lindemann M, Koldehoff M, Fiedler M, Schumann A, Ottinger HD, Heinemann FM, Roggendorf M, Horn PA, Beelen DW.Control of hepatitis B virus infection in hematopoietic stem cell recipients after receiving grafts from vaccinated donors. Bone Marrow Transplant. 2016 Mar; 51 (3): 428-431. 3.6
   
22. Nalivaiko K, Hofmann M, Kober K, Teichweyde N, Krammer PH, Rammensee HG, Grosse-Hovest L, Jung G. A Recombinant Bispecific CD20×CD95 Antibody With Superior Activity Against Normal and Malignant B-cells. Mol Ther. 2016 Feb; 24(2): 298-305. 6.2
   
23. Hönes JM, Botezatu L, Helness A, Vadnais C, Vassen L, Robert F, Hergenhan SM, Thivakaran A, Schütte J, Al-Matary YS, Lams RF, Fraszscak J, Makishima H, Radivoyevitch T, Przychodzen B, da Conceição Castro SV, Görgens A, Giebel B, Klein-Hitpass L, Lennartz K, Heuser M, Thiede C, Ehninger G, Dührsen U, Maciejewski J, Möröy T, Khandanpour C. GFI1 as a novel prognostic and therapeutic factor for AML/MDS. Leukemia. 2016 Jun; 30(6): 1237-1245. 10.4
   
24. Nardi FS, Slowik R, Michelon TF, Manvailer LFS, Wagner B, Neumann JM, Horn PA, Bicalho MG, Rebmann V. High amounts of total and extracellular vesicle-derived soluble HLA-G are associated with HLA-G 14bp deletion variant in embryo implantation failure women. Am J Reprod Immunol. 2016 Jun; 75(6): 661-671. 2.4
   
25. Lipinski KV, Sattler K, Peters S, Weske S, Keul P, Klump H, Heusch G, Göthert JR, Levkau B. Hepatocyte Nuclear Factor 1A Is a Cell-Intrinsic Transcription Factor Required for B Cell Differentiation and Development in Mice. J Immunol. 2016 Feb 15; 196(4): 1655-1665. 4.9
   
26. Zeuner MT, Patel K, Denecke B, Giebel B, Widera D. Paracrine effects of TLR4-polarised mesenchymal stromal cells are mediated by extracellular vesicles. J Transl Med. 2016 Feb 2; 14:34. 3.9
   
27. Börger V, Bremer M, Görgens A, Giebel B. Mesenchymal stem/stromal cell-derived extracellular vesicles as a new approach in stem cell therapy. ISBT Sci Ser. 2016; 11 (1): 228–234.  
   
28. Engert A, Balduini C, Brand A, Coiffier B, Cordonnier C, Döhner H, de Wit TD, Eichinger S, Fibbe W, Green T, de Haas F, Iolascon A, Jaffredo T, Rodeghiero F, Salles G, Schuringa JJ, […], Klump H, […], Zieger B. The European Hematology Association Roadmap for European Hematology Research: a consensus document. Haematologica. 2016 Feb; 101(2): 115-208. 6.7
   
29. Radtke S, Görgens A, Liu B, Horn PA & Giebel B. Human mesenchymal and murine stromal cells support human lympho-myeloid progenitor expansion but not maintenance of multipotent haematopoietic stem and progenitors cells. Cell Cycle. 2016 Mar 09; 15(4): 540-545. 5.0
   
30. König L, Kasimir-Bauer S, Hoffmann O, Bittner AK, Wagner B, Manvailer LF, Schramm S, Bankfalvi A, Giebel B, Kimmig R, Horn PA, Rebmann V. The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients. Hum Immunol. 2016 Sep; 77(9): 791–799. 2.3
   
2015 Impact Factor
1. Lener T, Gimona M, Ludwig Aigner L, Börger V, [...], Görgens A, [...], Horn PA, [...], Rohde E, Giebel B. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles. 2015; 4: 30087. 11.0
   
2. Denecke B, Horsch LD, Radtke S, Fischer JC, Horn PA, Giebel B. Human endothelial colony-forming cells expanded with an improved protocol are a useful endothelial cell source for scaffold-based tissue engineering.J Tissue Eng Regen Med. 2015 Nov; 9 (11): E84-97. 5.2
   
3. Murke F, Castro SVC, Giebel B, Görgens A. Concise Review: Asymmetric Cell Divisions in Stem Cell Biology. Symmetry. 2015 Nov 05; 7(4): 2025-2037. 0.8
   
4. Schumann A, Fiedler M, Beckebaum S, Cicinnati VR, Herzer K, Lenz V, Witzke O, Paul A, Roggendorf M, Horn PA, Lindemann M. Donor- and recipient-derived immunity in ABO incompatible living-related liver transplantation. Hum Immunol. 2015 Sep; 76(9): 631-635. 2.1
   
5. Loeffek S, Ullrich N, Görgens A, Murke F, Eilebrecht M, Menne C, Giebel B, Schadendorf D, Singer BB, Helfrich I. CEACAM1-4L promotes anchorage-independent growth in melanoma. Front Oncol. 2015 Oct 19; 5: 234. 4.1
   
6. Süsal C, Seidl C, Schönemann C, Heinemann FM, Kauke T, Gombos P, Arns W, Bauerfeind U, Hallensleben M, Einecke G, Hauser I, Kelsch K, Blasczyk R. Determination of unacceptable HLA antigen mismatches in kidney transplant recipients: recommendations of the German Society for Immunogenetics.Tissue Antigens. 2015 Nov; 86(5): 317-323. 2.1
   
7. Görgens A, Horn PA. From Basic Biology to Engineering and Clinical Translation of Stem Cells. Cellular Reprogramming. 2015 Dec 10; 17(6): 415-418. 1.8
   
8. Börger V, Görgens A, Rohde E, Giebel B. Therapeutisches Potenzial von extrazellulären Vesikeln aus mesenchymalen Stamm- bzw. Stromazellen. Transfusionsmedizin. 2015; 5: 131–137.  
   
9. Doeppner TR, Herz J, Görgens A, Schlechter J, Ludwig AK, Radtke S, de Miroschedji K, Horn PA, Giebel B and Hermann DM. Extracellular vesicles improve post-stroke neuroregeneration and prevent post-ischemic immunosuppression. Stem Cells Transl Med. 2015 Oct; 4(10): 1131-1143. 5.7
   
10. Görgens A, Giebel B. Wie unser Blut entsteht – neue Erkenntnisse zur Hämatopoese. BIOspektrum. 2015; 21(3): 290-293.  
   
11. Yáñez-Mó M, Siljander PRM, Andreu Z, [...], Giebel B, [...], Vasconcelos MH, Wauben MHM, De Wever O. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015; 4: 27066. 11.0
   
12. Graffmann N, Brands J, Görgens A, Vitoriano da Conceição Castro S, Santourlidis S, Reckert A, Michele I, Ritz-Timme S, Fischer JC, Adjaye J, Kögler G, Giebel B, Uhrberg M. Age-related increase of EED expression in early hematopoietic progenitor cells is associated with global increase of the histone modification H3K27me3. Stem Cells Dev. 2015 Sep 1; 24(17): 2018-2031. 4.2
   
13. LeMaoult J, Caumartin J, Daouya M, Switala M, Rebmann V, Arnulf B, Carosella ED. Trogocytic intercellular membrane exchanges among hematological tumors. J Hematol Oncol. 2015 Mar 14; 8: 24. 4.9
   
14. Barsegian V, Hueben C, Mueller SP, Poeppel TD, Horn PA, Bockisch A, Lindemann M. Impairment of lymphocyte function following yttrium-90 DOTATOC therapy. Cancer Immunol Immunother. 2015 Jun; 64(6): 755-764. 3.9
   
15. Koldehoff M, Lindemann M, Opalka B, Bauer S, Ross RS, Elmaagacli AH. Cytomegalovirus induces apoptosis in acute leukemia cells as a virus-versus-leukemia function. Leuk Lymphoma. 2015; 56(11): 3189-3197. 2.6
   
16. Radtke S, Görgens A, Kordelas L, Schmidt M, Kimmig KR, Köninger A, Horn PA, Giebel B. CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants. Br J Haematol. 2015 Jun; 169(6): 868-878. 5.0
   
17. Veit TD, Bogo Chies JA, Switala M, Wagner B, Horn PA, Busatto M, Viegas Brenol C, Tavares Brenol JC, Machado Xavier R, Rebmann V. The paradox of high availability and low recognition of soluble HLA-G by LILRB1 receptor in rheumatoid arthritis patients. PLoS ONE. 2015 Apr 08; 10 (4): e0123838. 3.5
   
18. Kefalakes H, Budeus B, Walker A, Jochum C, Hilgard G, Heinold A, Heinemann FM, Gerken G, Hoffmann D, Timm J. Adaption of hepatitis B virus core protein to CD8+ T cell selection pressure. Hepatology. 2015 Jul; 62(1): 47-56. 11.2
   
19. Schukfeh N, Lenz V, Metzelder M, Paul A, Mathe Z, Kathemann S, Hoyer PF, Dohna-Schwake C, Gerner P. First Case Studies of Successful ABO-Incompatible Living-Related Liver Transplantation in Infants in Germany. Eur J Pediatr Surg. 2015 Feb; 25(1): 77-81. 1.0
   
20. Kefalakes H, Jochum C, Hilgard G, Kahraman A, Bohrer AM, El Hindy N, Heinemann FM, Gerken G, Roggendorf M, Timm J. Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable. J Hepatol. 2015 Jul; 63(1): 13-19. 10.4
   
21. Seifert M, Przekopowitz M, Sarah Taudien S, Lollies A, Ronge V, Drees B, Lindemann M, Hillen U, Engler H, Singer BB, Kueppers R (2014): Functional capacities of human IgM memory B cells in early inflammatory responses and secondary germinal center reactions. Proc Natl Acad Sci USA. 2015 Feb 10; 112(6): E546-55. 9.8
   
22. Krawczyk A, Dirks M, Kasper M, Buch A, Dittmer U, Giebel B, Wildschütz L, Busch M, Goergens A, Schneweis KE, Eis-Hübinger AM, Sodeik B, Heiligenhaus A, Roggendorf M, Bauer D. Prevention of Herpes Simplex Virus Induced Stromal Keratitis by a Glycoprotein B-Specific Monoclonal Antibody. PLoS ONE. 2015 Jan 14; 10(1): e0116800. 3.5
   
23. Iacob S, Cicinnati VR, Heinemann FM, Lindemann M, Radtke A, Kaiser G, Kabar I, Schmidt HHJ, Baba HA, Beckebaum S. Donor specific anti-HLA antibodies and endothelial C4d deposition - association with chronic liver allograft failure. Transplantation. 2015 Sep; 99(9): 1869-1875. 3.5
   
24. Albring A, Wendt L, Harz N, Engler H, Wilde B, Kribben A, Lindemann M, Schedlowski M, Witzke O. Relationship between pharmacokinetics and pharmacodynamics of calcineurin inhibitors in renal transplant patients. Clin Transplant. 2015 Apr; 29(4): 294-300. 1.5
   
25. Kim DK, Lee J, Kim SR, Choi DS, Yoon YJ, [...], Giebel B, [...], Zeidler R, Gho YS. EVpedia: A Community Web Portal for Extracellular Vesicles Research. Bioinformatics. 2015 Mar 15; 31(6): 933-939. 4.6
   
   
2014 Impact Factor
1. Radtke S, Giebel B, Wagner W, Horn PA. Platelet lysates and their role in cell therapy. ISBT Science Series. 2014; 9(1): 193-197.  
   
2. Brandau S, Jakob M, Bruderek K, Bootz F, Giebel B, Radtke S, Mauel K, Jäger M, Flohé SB, Lang S. Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes. PLoS One. 2014 Sep 19; 9(9): e114201. 3.5
   
3. Müller CR, Mytilineos J, Ottinger H, Arnold R, Bader P, Beelen D, Bornhäuser M, Dreger P, Eiermann T, Einsele H, Faé I, Fischer G, Füssel M, Holler E, Holzberger G, Horn PA, Kröger N, Lindemann M, Seidl C, Spriewald B, Süsal C, Blasczyk R, Finke J. Deutscher Konsensus 2013 zur immungenetischen Spenderauswahl für die allogene Stammzelltransplantation. Transfusionsmedizin. 2014; 4: 190-196. 1.3
   
4. Riebschläger S. Vom Suchen und Finden - 25 Jahre nicht verwandte Blutstammzellspendersuche am Universitätsklinikum Essen. Transfusionsmedizin. 2014; 4: 187-9. 1.3
   
5. Sucker A, Zhao F, Real B, Heeke C, Bielefeld N, Massen S, Horn S, Moll I, Maltaner R, Horn PA, Schilling B, Sabbatino F, Lennerz V, Kloor M, Ferrone S, Schadendorf D, Falk CS, Griewank K, Paschen A. Genetic evolution of T-cell resistance in the course of melanoma progression. Clin Cancer Res. 2014 Dec 15; 20(24): 6593-6604. 8.2
   
6. Rebmann V, da Silva Nardi F, Wagner B, Horn PA. HLA-G as a tolerogenic molecule in transplantation and pregnancy. J Immunol Res. 2014; 2014: 297073. 2.9
   
7. Görgens A, Ludwig AK, Möllmann M, Krawczyk A, Dürig J, Hanenberg H, Horn PA, Giebel B. Multipotent hematopoietic progenitors divide asymmetrically to create progenitors of the Lympho-Myeloid and Erythro-Myeloid Lineages. Stem Cell Reports. 2014 Oct 23; 3(6): 1058-1072. 5.4
   
8. Lindemann M. Ex vivo assessment of cellular immune function – applications in patient care and clinical studies. Tissue Antigens. 2014 Nov; 84(5): 439-449. 2.8
   
9. Ziegler S, Skibbe K, Walker A, Ke X, Heinemann FM, Heinold A, Mok JY, van Esch WJE, Yang D, Wölfl M, Timm J. Impact of sequence variation in a dominant HLA-A*02-restricted epitope in HCV on priming and cross-reactivity of CD8+ T cells. J Virol. 2014 Oct; 88(19): 11080-11090. 5.1
   
10. Krawczyk A, Ludwig C, Jochum C, Fiedler M, Heinemann FM, Shouval D, Roggendorf M, Roggendorf H, Lindemann M. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine. Vaccine. 2014 Sep 3; 32(39): 5077-5082. 3.5
   
11. Malyar NM, Radtke S, Malyar K, Arjumand J, Horn PA, Kröger K, Freisinger E, Reinecke H, Giebel B, Brock FE. Autologous Bone Marrow Mononuclear Cell Therapy Improves Symptoms in Patients with End-Stage Peripheral Arterial Disease and Reduces Inflammation Associated Parameters. Cytotherapy. 2014 Sep; 16(9): 1270-1279. 3.3
   
12. Thoens C, Berger C, Trippler M, Siemann H, Lutterbeck M, Broering R, Schlaak J, Heinemann FM, Heinold A, Nattermann J, Scherbaum N, Alter G, Timm J. KIR2DL3+NKG2A- Natural Killer Cells are Associated with Protection from Productive Hepatitis C Virus Infection in People who Inject Drugs. J Hepatol. 2014 Sep; 61(3): 475-481. 9.9
   
13. Kordelas L, Verheyen J, Beelen DW, Horn PA, Heinold A, Kaiser R, Trenschel R , Schadendorf D, Dittmer U, Esser S. Shift of HIV Tropism in Stem-Cell Transplantation with CCR5 Delta32 Mutation. N Engl J Med. 2014 Aug 28; 371(9): 880-882. 54.4
   
14. Valencia K, Luis-Ravelo D, Bovy N, Antón I, Martínez-Canarias S, Zandueta C, Ormazábal C, Struman I, Tabruyn S, Rebmann V, De Las Rivas J, Guruceaga E, Bandrés E, Lecanda F. miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization. Mol Oncol. 2014 May; 8(3): 689-703. 6.7
   
15. Trettner S, Findeisen A, Taube S, Horn PA, Sasaki E, Zur Nieden NI. Osteogenic induction from marmoset embryonic stem cells cultured in feeder-dependent and feeder-independent conditions. Osteoporos Int. 2014 Apr; 25(4): 1255-1266. 4.0
   
16. Kordelas L, Rebmann V, Ludwig AK, Radtke S, Ruesing J, Doeppner TR, Epple M, Horn PA, Beelen DW, Giebel B. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia. 2014 Apr; 28(4): 970-973. 10.2
   
17. Hemeda H, Giebel B, Wagner W. Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells. Cytotherapy. 2014 Feb; 16(2): 170-180. 3.3
   
18. Berthelot L, Robert T, Tabary T et al. Transplantation basic science, allogenic and xenogenic tolerance. Nephrology, dialysis, transplantation. 2014; 29(3): iii528-iii538.  
   
19. Brandau S, Jakob M, Bruderek K, Bootz F, Giebel B.Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes. PLoS ONE. 2014 Sep 19; 9(9): e106903. 3.2
   
   
2013 Impact Factor
1. Guberina H, Heinemann F, Heinold A, Lindemann M, Eisenberger U, Horn PA, Witzke O (2013): Blutgruppeninkompatible Lebendnierentransplantation einer Patientin mit Spender-spezifischen Antikörpern. Transfusionsmedizin. 2013; 3: 191-195. 1.3
   
2. Martelli-Palomino G, Pancotto JA, Muniz YC, Mendes-Junior CT, Castelli EC, Massaro JD, Krawice-Radanne I, Poras I, Rebmann V, Carosella ED, Rouas-Freiss N, Moreau P, Donadi EA. Polymorphic Sites at the 3’ Untranslated Region of the HLA-G Gene Are Associated with Differential HLA-G Soluble Levels in the Brazilian and French Population. PLoS One. 2013 Oct 25; 8(10): e71742. 3.7
   
3. Görgens A, Radtke S, Horn PA, Giebel B. New Relationships of Human Hematopoietic Lineages Facilitate Detection of Multipotent Hematopoietic Stem and Progenitor Cells. Cell Cycle. 2013 Nov 15; 12(22): 3478-3482. 5.2
   
4. Krawczyk A, Roggendorf H, Ludwig C, Herzer K, Gerken G, Horn PA, Roggendorf M, Lindemann M. Therapeutic vaccination of a liver transplant recipient suffering from fulminant hepatitis B during pregnancy. Liver Transpl. 2013 Dec; 19(12): 1411-1412. 3.9
   
5. Lindemann M, Heinemann FM, Heinold A, Zaslavskaya M, Horn PA, Witzke O. Pneumococcal antibodies in kidney transplant recipients are predictive of patient survival. Scand J Immunol. 2013 Dec; 78(6): 554-556. 2.2
   
6. Radtke S, Horn PA. Pluripotent and Somatic Stem Cells: From Basic Science to Utilization in Disease Modeling and Therapeutic Application. Cell Reprogram. 2013 Oct; 15(5): 394-396. 2.7
   
7. Muturi HT, Dreesen, JD, Nilweski E, Jastrow H, Giebel B, Ergun S, Singer BB. Tumor and Endothelial Cell-Derived Microvesicles Carry Distinct CEACAMs and Influence T-Cell Behavior. PLOS One. 2013 Sep 11; 8(9): e74654. 3.7
   
8. Figueiredo C, Wedekind D, Mueller T, Vahlsing S, Horn PA, Seltsam A, Blasczyk R. MHC universal cells survive in an allogeneic environment after incompatible transplantation. BioMed Research International. 2013; Article ID 796046. doi: 10.1155/2013/796046. 2.9
   
9. Lindemann M, Heinemann FM, Horn PA, Witzke O. Vaccination against Streptococcus pneumoniae does not induce antibodies against HLA or MICA in clinically stable kidney transplant recipients. Hum Immunol. 2013 Oct; 74(10): 1267-1270. 2.3
   
10. Pajtler KW, Rebmann V, Lindemann M, Schulte JH, Schulte S, Stauder M, Leuschner I, Schmid KW, Köhl U, Schramm A, Eggert A. Expression of NTRK1/TrkA affects immunogenicity of neuroblastoma cells. Int J Cancer. 2013 Aug 15; 133(4): 908-919. 5.4
   
11. Bröcker V, Pfaffenbach A, Habicht A, Chatzikyrkou C, Kreipe HH, Haller H, Scheffner I, Gwinner W, Zilian E, Immenschuh S, Schwarz A, Horn PA, Heinemann FM, Becker JU. Beyond C4d: The ultrastructural appearances of endothelium in ABO-incompatible renal allografts. Nephrol Dial Transplant. 2013 Dec; 28(12): 3101-3109. 3.4
   
12. Heinrichs S, Conover LF, Bueso-Ramos CE, Kilpivaara O, Stevenson K, Neuberg D, Loh ML, Wu WS, Rodig SJ, Garcia-Manero G, Kantarjian HM, Look AT. MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy. Elife. 2013 Jul 16; 2: e00825. 8.5
   
13. Pilat S, Carotta S, Klump H. Development of Hematopoietic Stem and Progenitor Cells from Mouse Embryonic Stem Cells, In Vitro, Supported by Ectopic Human HOXB4 Expression. Methods Mol Biol. 2013; 1029: 129-147.  
   
14. Görgens A, Radtke S, Moellmann M, Cross M, Duerig J, Horn PA, Giebel B. Revision of the Human Hematopoietic Tree: Granulocyte Subtypes Derive from Distinct Hematopoietic Lineages. Cell Reports. 2013 May 30; 3(5): 1539-1552. 8.4
   
15. Klump H, Teichweyde N, Hinrichs C, Horn PA. Development of patient-specific hematopoietic stem and progenitor cell grafts from pluripotent stem cells, in vitro. Curr Mol Med. 2013 Jun; 13(5): 815-820. 5.1
   
16. Agustian PA, Bockmeyer CL, Modde F, Wittig J, Heinemann FM, Brundiers S, Dämmrich ME, Schwarz A, Birschmann I, Suwelack B, Jindra PT, Ahlenstiel T, Wohlschläger J, Vester U, Ganzenmüller T, Zilian E, Feldkamp T, Spieker T, Immenschuh S, Kreipe HH, Bröcker V, Becker JU. Glomerular mRNA Expression of Prothrombotic and Antithrombotic Factors in Renal Transplants With Thrombotic Microangiopathy. Transplantation May 27. 2013; 95(10): 1242-1248. 4.0
   
17. Krawczyk A, Arndt MAE, Grosse-Hovestc L, Weichert W, Giebel B, Dittmer U, Hengel H, Jäger D, Schneweis KE, Eis-Hübingerg AM, Roggendorf M, Krauss J. Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody. Proc Natl Acad Sci USA. 2013 Apr 23; 110(17): 6760-6765. 9.7
   
18. Alegre E, Rebmann V, Lemaoult J, Rodriguez C, Horn PA, Díaz-Lagares A, Echeveste JI, González A. In vivo identification of an HLA-G complex as ubiquitinated protein circulating in exosomes. Eur J Immunol. 2013 Jul; 43(7): 1933-1939. 5.1
   
19. Schilling B, Sucker A, Griewank K, Zhao F, Weide B, Görgens A, Giebel B, Schadendorf D, Paschen A. Vemurafenib reverses immunosuppression by myeloid derived suppressor cells. Int J Cancer. 2013 Oct 1; 133(7): 1653-1663. 5.4
   
20. Ziegler S, Ruhl M, Tenckhoff H, Wiese M, Heinemann FM, Horn PA, Spengler U, Neumann-Haefelin C, Nattermann J, Timm J.East-German HCV Study Group. Susceptibility to chronic hepatitis C virus infection is influenced by sequence differences in immunodominant CD8+ T cell epitopes. J Hepatol. 2013 Jan; 58(1): 24-30. 9.3
   
21. Arnold ML, Heinemann FM, Horn P, Ziemann M, Lachmann N, Mühlbacher A, Dick A, Ender A, Thammanichanond D, Fischer GF, Schaub S, Hallensleben M, Mytilineos J, Hitzler WE, Seidl C, Doxiadis II, Spriewald BM. Anti-HLA alloantibodies of the of IgA isotype in re-transplant candidates. Int J Immunogenet. 2013 Feb; 40(1): 17-20. 2.9
   
22. Heinold A, Opelz G, Döhler B, Unterrainer C, Scherer S, Ruhenstroth A, Tran TH. Deleterious Impact of HLA-DRB1 Allele Mismatch in Sensitized Recipients of Kidney Retransplants. Transplantation. 2013 Jan 15; 95(1): 137-141. 4.0
   
23. Adamek M, Heyder J, Heinold A, Fiedler G, Opelz G, Tran TH. Characterization of mannose-binding lectin (MBL) variants by allele-specific sequencing of MBL2 and determination of serum MBL protein levels. Tissue Antigens. 2013 Dec; 82(6): 410-415. 2.8
   
2012 Impact Factor
1. Trobridge G, Horn PA, Beard B, Kiem HP. Large Animal Models for Foamy Virus Vector Gene Therapy. Viruses. 2012 Nov; 4(12): 3572-3588. 1.5
   
2. Lesinski DA, Heinz N, Pilat-Carotta, S, Rudolph C, Jacobs R, Schlegelberger B, Klump H*, Schiedlmeier B. Serum- and stromal cell-free generation of embryonic stem cell-derived hematopoietic cells, in vitro, capable of multilineage repopulation of immunocompetent mice. Stem Cells Transl Med. 2012; 1(8): 581-591. (*co-correspondence) 3.6
   
3. Bellucci R, Nguyen HN, Martin A, Heinrichs S, Schinzel AC, Hahn WC, Ritz J. Tyrosine kinase pathways modulate tumor susceptibility to natural killer cells. J Clin Invest. 2012 Jul; 122(7): 2369–2383. 13.1
   
4. Sallmon H, Weber SC, Hüning B, Stein A, Horn PA, Metze BC, Dame C, Bührer C, Felderhoff-Müser U, Hansmann G, Koehne P. Thrombocytopenia in the First 24 Hours After Birth and Incidence of Patent Ductus Arteriosus. Pediatrics. 2012 Sep; 130(3): e623-630. 5.4
   
5. Roos M, Baumann M, Liu D, Heinemann FM, Lindemann M, Horn PA, Türk T, Lutz J, Heemann U, Witzke O, von Eynatten M. Low pre-transplant adiponectin multimers are associated with adverse allograft outcomes in kidney transplant recipients a 3-year prospective study. Regul Pept. 2012 Oct 10; 178(1-3): 11-15. 2.1
   
6. Iacob S, Cicinnati VR, Dechêne A, Lindemann M, Heinemann FM, Rebmann V, Ferencik S, Sotiropoulos GC, Popescu I, Horn PA, Gerken G, Paul A, Beckebaum S. Genetic, immunological and clinical risk factors for biliary strictures following liver transplantation. Liver Int. 2012 Sep; 32(8): 1253-1261. 3.8
   
7. Gortner L, Felderhoff-Müser U, Monz D, Bieback K, Klüter H, Jellema R, Kramer BW, Keller M, Reiss I, Horn PA, Giebel B. Regenerative Therapies in Neonatology: Clinical Perspectives. Klin Padiatr. 2012 Jul; 224(4): 233-240. 1.6
   
8. Goergens A, Beckmann J, Ludwig AK, Möllmann M, Dürig J, Horn PA, Rajendrand L, Giebel B. Lipid raft redistribution and morphological cell polarization are separable processes providing a basis for hematopoietic stem and progenitor cell migration. Int J Biochem Cell Biol. 2012 Jul; 1121-1132. 5.0
   
9. Doeppner TR, Ewert T AS, Tönges L, Herz J, Zechariah A, El-Ali A, Ludwig AK, Giebel B, Nagel F, Dietz PH, Weise J, Hermann DM, Bähr M. Transduction of Neural Precursor Cells with TAT-Hsp70 Chaperone: Therapeutic Potential Against Ischemic Stroke After Intrastriatal and Systemic Transplantation. Stem Cells. 2012 Jun; 30(6): 1297-1310. 7.8
   
10. Heyder J, Heinold A, Fiedler G, Opelz G, Tran TH. Characterization of four new HLA alleles: HLA-B*15:01:18, HLA-B*44:110, HLA-C*04:01:22 and HLA-DQB 1*05:14. Tissue Antigens. 2012 Mar; 79(3): 209-210. 3.0
   
11. González A, Rebmann V, LeMaoult J, Horn PA, Carosella ED, Alegre E. The immunosuppressive molecule HLA-G and its clinical implications. Crit Rev Clin Lab Sci. 2012 May-Jun; 49(3): 63-84. 5.7
   
12. Giebel B, Wodarz A. Notch Signaling: Numb Makes the Difference. Current Biology. 2012 Feb 21; 22(4): R133-135. 10.3
   
13. Elmaagacli AH, Koldehoff M, Lindemann M, Sonius M, Ditschkowski M, Steckel N, Beelen DW. Response: T cells are required for the CMV-induced antileukemia effect after transplant. Blood. 2012 Jan 26; 119(4): 1090-1. 10.6
   
14. Lindemann M, Heinemann FM, Horn PA, Witzke O: Long-term response to vaccination against pneumococcal antigens in kidney transplant recipients. Transplantation. 2012 Jul; 94(1): 50-56. 4.0
   
15. Kraemer M, Horn PA, Roder C, Khan N Diehl RR, Berlit P, Heinemann FM. Analysis of human leucocyte antigen genes in Caucasian patients with idiopathic Moyamoya angiopathy. Acta Neurochirurgica. 2012 Mar; 154(3): 445-454. 1.3
   
16. Esser S, Jablonka R, Heinemann FM, Reuter S, Jaeger H, Von Krosigk A, Schenk-Westkamp P, Schadendorf D, Horn PA, Lindemann M. Detection of abacavir hypersensitivity by ELISpot method. Inflamm Allergy Drug Targets. 2012 Jun; 11(3): 227-234.  
   
17. Vennemann MM, Loddenkötter B, Fracasso T, Mitchell EA, Debertin AS, Larsch KP, Sperhake JP, Brinkmann B, Sauerland C, Lindemann M, Bajanowski T. Cytokines and sudden infant death. Int J Legal Med. 2012 Mar; 126(2): 279-284. 2.9
   
18. Kraemer M, Heinemann FM, Horn PA, Venker C, Berlit P, Krischek B, Khan N. Inheritance of moyamoya disease in a Caucasian family. Eur J Neurol. 2012 Mar; 438-442. 3.8
   
19. Ludwig AK, Giebel B. EXOSOMES: Small vesicles participating in intercellular communication. Int J Biochem Cell Biol. 2012 Jan; 44(1): 11-15. 4.9
   
20. Ruhl M, Chhatwal P, Strathmann H, Kuntzen T, Bankwitz D, Skibbe K, Walker A, Heinemann FM, Horn PA, Allen TM, Hoffmann D, Pietschmann T, Timm J. Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope. J Virol. 2012 Jan; 86(2): 991-1000. 5.2
   
21. Nückel H, Castelli EC, Moreau P, Ochsenfarth C, Horn PA, Rebmann V. Simple Methods for the Detection of HLA-G Variants in Coding and Non-coding Regions. Methods Mol Biol. 2012; 882: 123-142.  
   
Buchbeiträge  
   
Lindemann M, Horn PA, DW Beelen. Zurück ins Leben – Wie sich das Immunsystem nach einer Blutstammzelltransplantation erholt. In: A. Eggert (Hrsg.): Translationale Krebsforschung – Auf dem Weg zu neuen Therapien. ISBN 978-3-934359-42-0.  
   
Lindemann M: Determination of nickel and chromium allergy, sensitization, and toxicity by cellular in vitro methods. In: K.-P. Wilhelm, H. Zhai, H.I. Maibach (Eds.): Dermatotoxicology, 8th edition, S. Karger AG, Basel 2012; 322-34 (eBook ISBN 9781841848570, ISBN 9781841848556)  
   
   
2011 Impact Factor
   
1. Wurm M, Gross B, Sgodda M, Ständker L, Müller T, Forssmann WG, Horn PA, Blasczyk R, Cantz T. Improved lentiviral gene transfer into human embryonic stem cells grown in co-culture with murine feeder and stroma cells. Biol Chem. 2011 Oct; 392(10): 887-895. 3.6
   
2. Radtke S, Horn PA, Cells, Niche, Fate: Meeting Report on the 6th International Meeting of the Stem Cell Network North Rhine Westphalia. Cell Reprogram. 2011 Oct; 13(5): 381-384. 2.4
   
3. Barsegian V, Müller SP, Horn PA, Bockisch A, Lindemann M. Lymphocyte function following radioiodine therapy in patients with thyroid carcinoma. Nuclear Medicine. 2011; 50(5): 195-203. 1.3
   
4. Ruhl M, Knuschke T, Schewior K, Glavinic L, Neumann-Haefelin C, Chang DI, Klein M, Heinemann FM, Tenckhoff H, Wiese M, Horn PA, Viazov S, Spengler U, Roggendorf M, Scherbaum N, Nattermann J, Hoffmann D, Timm J. CD8(+) T-cell response promotes evolution of hepatitis C virus nonstructural proteins. Gastroenterology. 2011 Jun; 140(7): 2064-2073. 12.9
   
5. Sokolova V, Ludwig AK, Hornung S, Rotan O, Horn PA, Epple M, Giebel B. Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B Biointerfaces. 2011 Oct 1; 87(1): 146-150. 2.6
   
6. Roos M, Heinemann FM, Lindemann M, Horn PA, Lutz J, Stock K, Thürmel K, Baumann M, Witzke O, Heemann U. Fetuin-A pretransplant serum levels, kidney allograft function and rejection episodes: A 3-year posttransplantation follow-up. Kidney Blood Press Res. 2011; 34(5): 328-333. 1.5
   
7. Elmaagacli AH, Steckel NK, Koldehoff M, Hegerfeldt Y, Trenschel R, Ditschkowski M, Christoph S, Gromke T, Kordelas L, Ottinger HD, Ross RS, Horn PA, Schnittger S, Beelen DW. Early human cytomegalovirus replication after transplant is associated with a decreased relapse-risk: evidence for a putative virus-versus-leukemia effect AML patients. Blood. 2011 Aug 4; 118(5): 1402-1412. 9.9
   
8. Lindemann M, Saure C, Klinkenbusch H, Valentin-Gamazo C, Horn PA, Cicinnati VR, Beckebaum S, Witzke O. Alloreactivity in recipients prior to and post living kidney and liver transplantation. Scand J Immunol. 2011 Apr; 73(4): 344-345. 2.2
   
9. Verloes A, Van de Velde H, Lemaoult J, Mateizel I, Cauffman G, Horn PA, Carosella ED, Devroey P, De Waele M, Rebmann V, Vercammen M. HLA-G Expression in Human Embryonic Stem Cells and Preimplantation Embryos. J Immunol. 2011 Feb 15; 186(4): 2663-2671. 5.6
   
10. Schulte I, Hitziger T, Giugliano S, Timm J, Gold H, Heinemann FM, Khudyakov Y, Strasser M, König C, Castermans E, Mok JY, van Esch WJ, Bertoletti A, Schumacher TN, Roggendorf M. Characterization of CD8+ T-cell response in acute and resolved hepatitis A virus infection. J Hepatol. 2011 Feb; 54(2): 201-208. 7.8
   
11. Kleinbongard P, Böse D, Baars T, Möhlenkamp S, Konorza T, Schöner S, Elter-Schulz M, Eggebrecht H, Degen H, Haude M, Levkau B, Schulz R, Erbel R, Heusch G. Vasoconstrictor Potential of Coronary Aspirate From Patients Undergoing Stenting of Saphenous Vein Aortocoronary Bypass Grafts and Its Pharmacological Attenuation. Circ Res. 2011 Feb 4; 108(3): 344-352. 9.2
   
12. Warlich E, Kuehle J, Cantz T, Brugman MH, Maetzig T, Galla M, Filipczyk AA, Halle S, Klump H, Schöler HR, Baum C, Schroeder T, Schambach A. Lentiviral Vector Design and Imaging Approaches to Visualize the Early Stages of Cellular Reprogramming. Mol Ther. 2011 Apr; 19(4): 782-789. 6.2
   
13. Rizzo R, Vercammen M, van de Velde H, Horn PA, Rebmann V. The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells. Cell Mol Life Sci. 2011 Feb; 68(3): 341-352. 6.1
   
Buchbeiträge  
   
Horn PA. (2011): Reprogrammierung von Stammzellen. In: Anna Seemüller (Hrsg.): Transformationen - Interdisziplinäre Betrachtungen. Cuvillier Verlag Göttingen, S. 115–124 (ISBN 978-3-86955-878-3)  
   
Klump H, Elter-Schulz M. Herausforderungen der Transfusionsmedizin - Blutprodukte für Patienten in Hämatologie und Onkologie. WTZ-Journal 3, 2011; 16-19 (LUKON Verlagsgesellschaft mbH · ISSN: 1869-5892)  
   
Klump H, Horn PA. Somatische Gentherapie von blutbildenden Stammzellen (CME-Fortbildung). Transfusionsmedizin 2011; 1–12 (Georg Thieme Verlag KG · VNR 2760512011062200204 · ISSN 2191-8805ISSN 2191-8805)  
   
   
2010 Impact Factor
   
1. Lindemann M, Heinemann FM, Horn PA, Witzke O. Immunity to pneumococcal antigens in kidney transplant recipients. Transplantation. 2010 Dec 27; 90(12): 1463-1467. 3.7
   
2. Wild CA, Brandau S, Lindemann M, Hoffmann TK, Lang S, Bergmann C.: Toll-like receptors in regulatory T cells of patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2010 Dec; 136(12): 1253-1259. 1.8
   
3. Stocking C, Grez M, Fehse B, von Laer D, Itoh K, Prassolov V, Nowock J, Kühlcke K, Just U, Schröder T, Klump H, Schiedlmeier B, Grassman E, Meyer J, Li Z, Schambach A, Modlich U, Kustikova O, Galla M, Bode J, Zander A, Baum C. Cell and virus genetics at the roots of gene therapy, retrovirology, and hematopoietic stem cell biology: Wolfram Ostertag (1937-2010). Hum Gene Ther. 2010 Nov; 21(11): 1501-1503. 4.2
   
4. Sattler KJ, Elbasan S, Keul P, Elter-Schulz M, Bode C, Gräler MH, Bröcker-Preuss M, Budde T, Erbel R, Heusch G, Levkau B. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease. Basic Res Cardiol. 2010 Nov; 105(6): 821-832. 5.9
   
5. Figueiredo C, Goudeva L, Horn PA, Eiz-Vesper B, Blasczyk R, Seltsam A. Generation of HLA-deficient platelets from hematopoietic progenitor cells. Transfusion. 2010 Aug; 50(8): 1690-1701. 2.9
   
6. Lindemann M, Nyadu B, Heinemann FM, Kribben A, Paul A, Horn PA, Witzke O. High negative predictive value of an amplified flow cytometry crossmatch prior to living donor kidney transplantation. Hum Immunol. 2010 Aug; 71(8): 771-776. 3.1
   
7. Rebmann V, Switala M, Eue I, Grosse-Wilde H. Soluble HLA-G is an independent factor for the prediction of pregnancy outcome after ART: A German Multi-Centre Study. Hum Reprod. 2010 Jul; 25(7): 1691-1698. 3.9
   
8. Nückel H, Switala M, Sellmann L, Horn PA, Dürig J, Dührsen U, Küppers R, Grosse-Wilde H, Rebmann V. The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia. Leukemia. 2010 Jun; 24(6): 1152-1159. 8.6
   
9. Schütt P, Schütt B, Switala M, Bauer S, Stamatis G, Opalka B, Eberhardt W, Schuler M, Horn PA, Rebmann V. Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients. Hum Immunol. 2010 May; 71(5): 489-495. 3.1
   
10. Hemeda H, Jakob M, Ludwig AK, Giebel B, Lang S, Brandau S. Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells. Stem Cells Dev. 2010 May; 19(5): 693-706. 4.1
   
11. Röth A, Peine S, Dührsen U. Paroxysmal nocturnal hemoglobinuria turning Coombs-positive. Int J Hematol. 2010 Mar; 91(2): 159-160. 1.3
   
12. Bayerer B, Engelbergs J, Savidou I, Boes T, Kuper M, Schorn CF, Wissmann A, Knop D, Diener HC, Limmroth V. Single nucleotide polymorphisms of the serotonin transporter gene in migraine - an association study. Headache. 2010 Feb; 50(2): 319-322. 3.1
   
13. Wurm M, Schambach A, Lindemann D, Hanenberg H, Ständker L, Forssmann WG, Blasczyk R, Horn PA. The influence of semen-derived enhancer of virus infection on the efficiency of retroviral gene transfer. J Gene Med. 2010 Feb; 12(2): 137-146. 2.9
   
14. Moog R, Reichenberg S, Hoburg A, Müller N. Quality of methylene-blue-treated fresh-frozen plasma stored up to 27 months.Transfusion. 2010 Feb; 50(2): 516-518. 3.5
   
15. Radtke S, Görgens A, Punzel M, Horn PA, Giebel B.Establishment of an extended in vitro assay to detect the most primitive human hematopoietic cells at a clonal level. J Stem Cells Regen Med. 2010 Oct 23; 6(2): 48.  
   
16. Goergens, A; Beckmann, J; Rajendran, L; Horn, PA; Giebel, B. Functional analyses of cell polarity organization in human hematopoietic stem and progenitor cells. 2010 Oct 23; 6(2): 74.  
   
Buchbeiträge  
   
Müller KD, Schmid EN, Lindemann M, Müller G, Mosel F, Rettenmeier AW, Michel R (2010): KC 5/2, an unusual endocytobiont of acanthamoebae and monocytic cells. Abstractband 2010, BIOSpektrum, Chefredakteur: C. Schreiber, Editoren: B. Trageser, Spektrum Akademischer Verlag, S. 101, FTP20.  
   
Esser S, von Krosigk A, Jäger H, Reuter S, Jablonka R, Heinemann F, Horn P, Lindemann M (2010). Detektion der Abacavir-Hypersensitivität mittels ELLISpot-Methode. In: Hoffmann/Jäger (Ed.): HIV/AIDS besiegen: Visionen der Heilung; AIDS und HIV-Infektionen in Klinik und Praxis, Monographiereihe, Verlag Wiley-Blackwell, Berlin, 13: 9.  
   
Rebmann V. Grosse-Wilde H (2010): Tumour-specific and tumour-associated antigens. In: Stavrou DK, Hagel C (Eds.): Immune Biology of Brain Tumours, Dustri-Verlag Dr. Karl Feiste Munich – Orlando, 7-21.  
   
Rebmann V. Grosse-Wilde H (2010): Immunological mechanisms of tumour cell destruction. In:Stavrou DK, Hagel C (Eds.): Immune Biology of Brain Tumours, Dustri-Verlag Dr. Karl Feistle, Munich – Orlando, 23-31.  
   
Görgens A, Giebel B. (2010): Self-Renewal of Primitive Hematopoietic Cells: A Focus on Asymmetric Cell Division, Kapitel 3 in “Umbilical Cord Blood: A Future for Regenerative Medicine?” Editors: Suzanne Kadereit, Gerald Udolph. World Scientific Publishing, 51-75.  
   
2009 Impact Factor
   
1. DeLuca DS, Beisswanger E, Wermter J, Horn PA, Hahn U, Blasczyk R. MaHCO: an ontology of the major histocompatibility complex for immunoinformatic applications and text mining. Bioinformatics. 2009 Aug; 25(16): 2064-2070. 4.3
   
2. Nückel H, Switala M, Collins CH, Sellmann L, Grosse-Wilde H, Dührsen U, Rebmann V. High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia. Clin Immunol. 2009 Jun; 131(3): 472-480. 3.6
   
3. Henneberg-Quester KB, Fuchs N, Holtmann M, Knop D, Mueller N., Horn PA, Peine SO. Consistent Error Reporting Reduces Blood Sample Mislabelling. Transfus Med Hemother. 2009; 36 (suppl 1): 56-57. 3.5
   
4. Fleischmann G, Horn PA. Pluripotency and reprogramming: meeting report on the Fifth International Meeting of the Stem Cell Network North Rhine Westphalia. Cloning Stem Cells. 2009 Dec; 11(4): 473-475. 2.6
   
5. Lindemann M, Dioury Y, Beckebaum S, Cicinnati VR, Gerken G, Broelsch CE, Wrighton-Smith P, Grosse-Wilde H. Diagnosis of tuberculosis infection in patients awaiting liver transplantation. Hum Immunol. 2009 Jan; 70(1): 24-28. 3.1
   
6. Fleischmann G, Müller T, Blasczyk R, Sasaki E, Horn PA. Growth characteristics of the nonhuman primate embryonic stem cell line cjes001 depending on feeder cell treatment. Cloning Stem Cells. 2009 Jun; 11(2): 225-233. 2.6
   
7. Rebmann V, Bartsch D, Wunsch A, Möllenbeck P, Golda T, Viebahn R, Grosse-Wilde H. Soluble total human leukocyte antigen class I and human leukocyte antigen-G molecules in kidney and kidney/pancreas transplantation. Hum Immunol. 2009 Dec; 70(12): 995-999. 3.1
   
8. Müller T, Fleischmann G, Eildermann K, Mätz-Rensing K, Horn PA, Sasaki E, Behr R. A novel embryonic stem cell line derived from the common marmoset monkey (Callithrix jacchus) exhibiting germ cell-like characteristics. Hum Reprod. 2009 Jun; 24(6): 1359-1372. 3.8
   
9. Moog R. Feasibility and safety of triple dose platelet collection by apheresis. J Clin Apheresis. 2009; 24(6): 238-240. 1.8
   
10. Cicinnati VR, Kang JY, Hou J, Lindemann M, Koop K, Tuting T, Gerken G, Beckebaum S. Interferon-alpha differentially affects homeostasis of human plasmacytoid and myeloid dendritic cells. J Interferon Cytokine Res. 2009 Mar; 29(3): 145-159. 1.8
   
11. Wiegand J, Luz B, Mengelkamp AK, Moog R, Koscielny J, Halm-Heinrich I, Susemihl C, Bentzien F, Diekmann J, Wernet D, Karger R, Angert K, Schmitt-Thomssen A, Kiefel V, Lutter K, Hesse R, Kätzel R, Opitz A, Luhm J, Barz D, Leib U, Matthes G, Tillmann HL. Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: epidemiological benefit from established health resources. J Viral Hepat. 2009 Oct; 16(10): 743-748. 3.3
   
12. Hinrichs J, Figueiredo C, Hirv K, Mytilineos J, Blasczyk R, Horn PA, Eiz-Vesper B. Discrimination of HLA null and low expression alleles by cytokine-induced secretion of recombinant soluble HLA. Mol Immunol. 2009 Apr; 46(7): 1451-1457. 3.6
   
13. Rajendran L, Beckmann J, Magenau A, Boneberg EM, Gaus K, Viola A, Giebel B, Illges H. Flotillins are involved in the polarization of primitive and mature hematopoietic cells. PLoS ONE. 2009 Dec 22; 4(12): e8290. 2.1
   
14. Figueiredo C, Jaimes Y, Horn PA, Blasczyk R, Eiz-Vesper B. The new HLA-Cw*0524 allele increase the variability of position 49 in HLA-C. Tissue Antigens. 2009 Sep; 74(3): 258-259. 2.1
   
15. Wienzek S, Verboom M, Blasczyk R, Bein G, Horn PA. DQB1*0323 is the result of a gene conversion event between a DQB1*06 and a DQB1*030303 allele. Tissue Antigens. 2009; 73(6): 624-625. 2.1
   
16. Moog R. Retention of prospective donors: a survey about services at a blood donation centre. Transfus Apher Sci. 2009 Jun; 40(3): 149-152. 1.0
   
17. Moog R. 2008 Congress of the ESFH in Düsseldorf, Germany. Transfus Apher Sci. 2009 Aug; 41(1): 23-26. 1.0
   
18. Heinemann FM. HLA genotyping and antibody characterization using the Luminex (TM) multiplex technology. Transfus Med Hemother. 2009; 36(4): 273-278. 0.5
   
19. Cicinnati VR, Hou J, Lindemann M, Horn PA, Sotiropoulos GC, Paul A, Gerken G, Beckebaum S. Mycophenolic acid impedes the antigen presenting and lymph node homing capacities of human blood myeloid dendritic cells. Transplantation. 2009 Aug 27; 88(4): 504-513. 3.8
   
20. Schumann A, Lindemann M, Valentin-Gamazo C, Lu M, Elmaagacli A, Dahmen U, Knop D, Broelsch CE, Grosse-Wilde H, Roggendorf M, Fiedler M. Adoptive immune transfer of hepatitis B virus specific immunity from immunized living liver donors to liver recipients. Transplantation. 2009 Jan 15; 87(1): 103-111. 3.8
   
Buchbeiträge  
   
Heinemann FM, Nyadu B, Kribben A, Paul A, Witzke O, Horn PA, Lindemann M (2009): Predictive value of the flow cytometry cross-match in living kidney transplantation. In: P.I. Terasaki (Ed.): Visuals of the 10th European Clinical Histocompatibility Workshop, Evian-les-Bains, France. One Lambda, Inc.: 10-1.  
   
Schumann A, Lindemann M, Fiedler M (2009): Transfer der Hepatitis-B-Immunität durch Leber-Lebend-Transplantation. In: Selbsthilfe Lebertransplantierter Deutschland e.V. (Ed.): Hepatologie. Lebenslinien, 1: 15-6.  
   
Fleischmann G, Figueiredo C, Seltsam A, Blasczyk R, Horn PA. (2009): Embryonic Stem Cells: MHC Expression and Immunogenicity of Stem Cell-Derived Cellular Therapeutics. In: Advances in Medicine and Biology. Volume 1, ISBN: 978-1-60876-863-9: 165-198  
   
2008 Impact Factor
   
1. Moog R. Therapeutic apheresis - Many ways to go Transfus Med Hemother. 2008; 35(1): 5-6. 0.6
   
2. Moog R. Management strategies for poor peripheral blood stem cell mobilization. Transfus Apher Sci. 2008; 38(3): 229-36. 0.9
   
3. Emmerich F, Schönemann C, Diederich G, Horn PA, Salama A. Identification of a novel HLA-DQB1 allele, HLA-DQB1*0632. Tissue Antigens. 2008; 71(1): 94-5. 2.3
   
4. Albis-Camps M, Blasczyk R, Horn PA. Haplotype-specific sequence-based typing shows the novel allele HLA-A*030105. Tissue Antigens. 2008; 71(1): 85-6. 2.3
   
5. Barsegian V, Mathias KD, Wrighton-Smith P, Grosse-Wilde H, Lindemann M. Prevalence of latent tuberculosis infection in German radiologists. J Hosp Infect. 2008; 69(1): 69-76. 3.0
   
6. Schütt P, Rebmann V, Brandhorst D, Wiefelspütz J, Ebeling P, Opalka B, Seeber S, Nowrousian MR, Moritz T, Grosse-Wilde H. The clinical significance of soluble human leukocyte antigen class-I, ICTP, and RANKL molecules in multiple myeloma patients. Hum Immunol. 2008; 69(2): 79-87. 2.6
   
7. Giebel B, Bruns I. Self-renewal versus differentiation in hematopoietic stem and progenitor cells: a focus on asymmetric cell divisions. Curr Stem Cell Res Ther. 2008; 3(1): 9-16. 3.6
   
8. Wurm M, Horn PA. Reprogramming, regeneration, and the stem cell niche: meeting report on the 4th International Meeting of the Stem Cell Network North Rhine Westphalia. Cloning Stem Cells. 2008; 10(2): 183-8. 2.7
   
9. Lindemann M, Rietschel F, Zabel M, Grosse-Wilde H. Detection of chromium allergy by cellular in vitro methods. Clin Exp Allergy. 2008; 38(9): 1468-75. 4.1
   
10. Giebel B. Cell polarity and asymmetric cell division within human hematopoietic stem and progenitor cells. Cells Tissues Organs. 2008; 188(1-2): 116-26. 2.4
   
11. Beier D, Röhrl S, Pillai DR, Schwarz S, Kunz-Schughart LA, Leukel P, Proescholdt M, Brawanski A, Bogdahn U, Trampe-Kieslich A, Giebel B, Wischhusen J, Reifenberger G, Hau P, Beier CP. Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Res. 2008; 68(14): 5706-15. 7.5
   
12. Seidel MG, Peters C, Wacker A, Northoff H, Moog R, Boehme A, Silling G, Grimminger W, Einsele H. Randomized phase III study of granulocyte transfusions in neutropenic patients. Bone Marrow Transplant. 2008; 42(10): 679-84. 2.9
   
13. Chan KM, Bonde S, Klump H, Zavazava N. Hematopoiesis and immunity of HOXB4-transduced embryonic stem cell-derived hematopoietic progenitor cells. Blood. 2008; 111(6): 2953-61. 10.4
   
14. Giebel B, Punzel M. Lineage development of hematopoietic stem and progenitor cells. Biol Chem. 2008; 389(7): 813-24. 3.0